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Chronic shoulder pain is a major problem in the UK. The most effective non-surgical 
management of chronic shoulder pain is unknown. Suprascapular nerve block (SSNB) injections 
are one treatment option used in the management of chronic shoulder pain however little is 
known about its use and application in clinical practice.  
Objectives 
This study aimed to explore the experiences and views of clinicians who use SSNB injections 
for the non-surgical management of shoulder pain. The main objective was to gain an in-depth 
understanding regarding the application of SSNB injections in clinical practice. The findings may 
go on to inform future research in this area.  
Design  
A pragmatic qualitative approach was adopted and underpinned this study. 
Methods 
One rheumatologist, one pain consultant and three physiotherapists who currently use SSNB 
injections in the non-surgical management of shoulder pain participated in a focus group. The 
focus group was recorded, transcribed and then analysed using thematic analysis.  
Findings 
Three main themes were identified; Patient Selection, The Intervention and Patient 
Management. Clinicians in this study currently reserve SSNB injections for patients with long 
standing shoulder pain that has failed to improve with other treatments including local steroid 
injections. Variation exists in the approach taken to administer the nerve block as well as the 
drugs, dosages and volumes used. All clinicians reported that physiotherapy and shoulder 
exercises played an important part in the overall management of their patients after receiving a 
SSNB injection.  
Limitations 
A major limitation of this study was that only one focus group was undertaken. Undertaking a 
number of focus groups across a wider geographical region that included the views and 
experiences of orthopaedic consultants, interventional radiologists and general practitioners 
would strengthen the findings of this study. Using additional methods such as individual 
interviews and surveys for triangulation would also improve the credibility of the findings.  
Conclusion 
Clinicians recognise the lack of theory and evidence guiding clinical practice in this area. Based 
upon the findings of this small group of clinicians, most felt that SSNB injections may have a 
wider role to play in managing shoulder pain. Future research may be aimed at targeting 
specific patient groups with shoulder pain earlier for a SSNB injection, rather than waiting to see 
if other treatments have failed. This study has provided background information that may be 
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Background and Introduction 
Background to this research project 
 
I am a Physiotherapist with over 17 years of experience in clinical practice in the 
NHS, of which 15 years have been based within a community musculoskeletal 
physiotherapy service and a community integrated clinical assessment and 
treatment service (iCATS) from Sandwell and West Birmingham Hospitals NHS 
Trust.  I have a special interest in treating shoulder pain and have previously 
undertaken Masters level training in; Injection Therapy, Upper Limb 
Orthopaedics, Applied Orthopaedic Radiology and Project Management and 
Research Governance as stand-alone modules at Coventry University, Salford 
University and Birmingham University. Within my service, the use of local 
steroid injections in the treatment of chronic shoulder pain is long standing and 
an accepted practice. I have used local steroid injections in the management of 
shoulder pain since 2007. As part of a redesign of local musculoskeletal, 
orthopaedic and pain management pathways in 2014, I was trained and started 
to administer suprascapular nerve block (SSNB) injections for patients with 
chronic shoulder pain in community clinics. However, as a service we had no 
clear criteria regarding which patients should be considered for SSNB injections 
and no understanding on ‘best practice’ regarding the long term management of 
patients following a SSNB injection. Prior to 2014, SSNB injections were only 
offered within specialist pain clinics in secondary care in my trust.  
This research project evolved from my own experiences and questions that 
arose from using SSNB injections treating patients with chronic shoulder pain in 
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clinical practice. Whilst undertaking a NIHR Clinical Academic Internship 
Program (CAIP) I was able to develop further understanding of research 
methods and application that facilitated the development of my initial ideas for 
undertaking this research project. I recognised that this project would require a 
programme of research, involving both qualitative and quantitative approaches, 
adopting an evolving phased approach. Phase 1 was undertaken within this 
NIHR funded MRes programme and involved an exploratory study aiming to 
develop a greater understanding regarding the application of SSNB injections in 
clinical practice. The findings of this preliminary research may go on to inform 




Prevalence and Incidence of shoulder pain in the UK 
Shoulder problems are a major cause of pain and disability in the United 
Kingdom and symptoms may become chronic, recurrent and persistent, 
affecting the quality of life of many patients (Lowe et al, 2014, Murphy & Carr, 
2010). Chronic pain may be defined as pain lasting longer than 3 months 
(Merskey 1986). Accurate estimates of the number of people living with chronic 
shoulder pain in the UK is currently unknown due to the paucity of up to date 
literature. In the year 2000, estimates of the annual prevalence and incidence of 
people accessing in primary care, in the UK, with shoulder related pain was 
2.4% and 1.5% respectively (Linsell et al, 2006). This study also highlighted the 
issue of chronic shoulder pain with around 20% of people with a shoulder 
problem, still reporting shoulder pain at 1 year and 13.6% of patients still 
reporting shoulder pain at 3 years (Linsell et al, 2006). 
The literature also indicates that chronic shoulder pain is more prevalent with 
advancing age (Vecchio et al, 1995, Chard et al, 1991). Linsell et al, (2006) 
identified that older patients were more likely to have chronic shoulder pain, 
17.6% of over 60 year olds with shoulder related symptoms were still reporting 
pain 2 years on from their initial presentation.  
Although the literature indicates that shoulder pain is a common condition, that 
may become chronic in many patients, a systematic review undertaken by 
Luime et al, (2004) highlighted problems associated with interpreting the 
findings from some epidemiological studies measuring estimates of shoulder 
pain in the general population. Variability in case definition, inconsistent 
reporting and variability in the ability to diagnose and define shoulder 
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conditions, by clinicians in general practice were highlighted as issues 
associated with inconsistent findings within and between epidemiological 
studies (Luime et al, 2004). This variability in defining and diagnosing shoulder 
pain may have implications in managing shoulder pain in primary care. 
Clinicians in general practice may lack confidence in managing shoulder pain 
when a specific diagnosis is not always clear.  
Physiotherapy management is recognised as one of the first treatment options 
in the management of shoulder problems (Murphy & Carr, 2010). The overall 
number of patients attending musculoskeletal physiotherapy services in the UK 
with a shoulder related problem is currently unknown. However, audit data from 
individual services indicates that shoulder pain is the third most common 
musculoskeletal problem for someone seeing a physiotherapist (May 2003) or 
being referred to a Musculoskeletal Clinical Assessment and Treatment Service 
(CATs) (Roddy et al, 2013). Evidence indicates that many patients with 
shoulder pain benefit from physiotherapy management (Kuhn et al, 2009, Green 
et al, 2003), however not all patients improve sufficiently and some patients go 
on to develop chronic, recurrent and persistent shoulder pain (Chester et al, 
2013). 
 
Chronic shoulder pain 
Based upon the IASP (1986) definition of chronic pain i.e. pain lasting 3 months 
or more, clearly many people with shoulder pain could therefore be classified 
has having chronic pain (Merskey 1986). Although some chronic 
musculoskeletal conditions continue to have an underlying, ongoing or episodic 
inflammatory component, such as in rheumatoid arthritis (RA) and osteoarthritis, 
recent advances in our understanding and knowledge of pain neurophysiology 
 12 
questions whether all chronic pain conditions are solely maintained and driven 
by ongoing peripheral tissue pathology (Aronoff 2016,  Littlewood et al, 2013, 
Gifford 1998).  
The mismatch between tissue pathology and pain perception is demonstrated 
by the fact that many people with shoulder pathology, for example a rotator cuff 
tear identified on imaging, may experience very little pain (Lewis 2016, 
Littlewood et al, 2013). In addition, improvements in pain following surgical 
rotator cuff repair have not been shown to be dependent upon successful repair 
of the tear, implying that structural pathology alone i.e. a rotator cuff tear, is not 
the only factor in pain perception in some patients with shoulder pain (Yang et 
al, 2016, Flurin et al, 2007).  
Recent literature identifies the potential role of the peripheral and central 
nervous system, in maintaining and driving ongoing symptoms (central 
sensitization), in some patients with chronic shoulder pain (Bradnam et al, 2016, 
Borstad & Woeste 2015, Lewis 2016, Lewis et al, 2015, Sanchis et al, 2015, 
Dean et al, 2013, Littlewood et al, 2013, Paul et al, 2012, Gwilym et al, 2011). 
Central sensitization refers to ’an amplification of neural signaling within the 
central nervous system that elicits pain hypersensitivity’ (Woolf, 2011).  Central 
sensitization may play a role in some patients with chronic shoulder pain, 
although the mechanism by which central sensitization becomes established is 
not well understood (Sanchis et al, 2015). A lowering of the threshold of 
activation for pain perception may exist in some individuals. In this situation, 
essentially a variety of sensory afferent input to the CNS, that in a non-
sensitized state or individual would not normally be perceived as painful, may 
now be sufficient to trigger and maintain pain perception. Clinically and 
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functionally simple normally non-provocative shoulder movements or palpation 
around the shoulder may now be perceived as painful (Dean et al, 2013, 
Basbaum 2009). 
Recognition that not all chronic shoulder pain conditions are necessarily driven 
or maintained by peripheral tissue pathology, damage or inflammation, 
challenges traditional concepts of diagnosing and managing shoulder pain, and 
may have important implications in clinical practice when deciding on the most 
appropriate treatment and management strategies for some patients with 
chronic shoulder pain. Solely targeting treatments at peripheral pathology may 
be futile in some patients. Some authors have argued for a ‘mechanism-based 
approach’ to diagnosing, managing and targeting pain interventions in chronic 
pain (Vardeh et al, 2016). Treatment and management strategies targeting the 
‘mechanisms’ that contribute to chronic shoulder pain, may provide more 
effective care and improve outcomes in the future for some patients. However, 
recognizing and identifying the mechanisms involved in chronic shoulder pain, 
in order, to target them with more specific treatments, remains a challenge, due 
to the lack of validated clinical tools that can identify such mechanisms in 
clinical practice and the availability of effective therapeutic modalities (Woolf 
2011, Smart et al, 2011).  
Local steroid injections 
The most effective non-surgical management for shoulder pain is unknown 
(Green et al, 2003). Local steroid injections offer some patients with shoulder 
pain short term benefit in pain relief and improvements in function (Buchbinder 
et al, 2003). First discovered by Philip Hench in the 1940’s, glucocorticosteroids 
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are potent anti-inflammatory agents and are commonly used for local steroid 
injection preparations (Buchbinder et al, 2003, Hench et al, 1949). Although 
local steroid injections are often used in clinical practice there is uncertainty 
about their long-term benefits in addition to physiotherapy (Crawshaw et al, 
2010). Expert opinion and clinician consensus indicates that local steroid 
injections are considered an important treatment option within the overall 
management of shoulder conditions (Bryceland et al, 2015, Griffiths and 
Yohannes 2014, Kulkarni et al, 2015).  
Injection therapy was adopted within the scope of physiotherapy by the 
Chartered Society of Physiotherapy (CSP) in 1995 and physiotherapists who 
have undergone specific post graduate training are able to administer and use 
injection therapy within their practice. Injection therapy combined with shoulder 
exercises, delivered by physiotherapists, was demonstrated to be a cost-
effective model of care that may lead to earlier recovery, including patients 
returning to work sooner, when compared to treatment with exercises alone, in 
some patients with shoulder pain (Jowett et al, 2013, Crawshaw et al, 2010).  
In a survey of current physiotherapy practice, around 35% of respondents 
reported that local steroid injections were considered within the overall 
management strategy for patients with rotator cuff related pain (Littlewood et al, 
2012). In a separate survey on the physiotherapy management of frozen 
shoulder around 80% of respondents reported that administration of local 
steroid injections would be considered in patients with frozen shoulder, 
especially when pain rather than stiffness was the main problem (Hanchard et 
al, 2011).  Based on the above survey findings and on the data from service 
evaluation, local steroid injections appear to be regularly considered and used 
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by physiotherapists in the treatment and management of shoulder disorders in 
the UK (Roddy et al, 2013, Littlewood et al, 2012, Hanchard et al, 2011).  
Local steroid injections have risks and potential side effects including local 
tissue atrophy and depigmentation, local tendon rupture, local infection, post 
injection flare, steroid arthropathy, or more widespread and systemic side 
effects such has allergic reaction, facial flushing, menstrual irregularity and 
elevated blood sugar in diabetic patients (Brinks et al, 2010, Saunders and 
Longworth 2006). The negative effects that glucocorticoid steroids have on 
tendon homeostasis, that may result in tendon weakening, potentially resulting 
in worse long-term outcomes for patients, has also received renewed interest in 
the literature (Ackermann and Hart 2016 page 229 and 239, Dean et al, 2014a, 
Dean et al, 2014b, Coombes et al, 2010). Local steroid injections may have a 
negative effect on rotator cuff tendon homeostasis and integrity and arguably 
this should be a consideration within the overall decision-making process in 
clinical practice, especially when repeated local steroid injections are being 
considered. In clinical practice clinicians may often have to make decisions 
regarding administering repeat local steroid injections with the dilemma and 
knowledge that although it may provide short term pain relief and facilitate 
rehabilitation, it may also may have a negative effect on tendon homeostasis 
and long term outcome.  
Although glucocorticosteroids have potent anti-inflammatory properties, the 
mechanism by which local steroid injections relieve symptoms in patients with 
chronic shoulder pain has not been widely investigated. It is possible that, apart 
from their local anti-inflammatory actions, other systemic effects of 
glucocorticosteroids, may, in some part, be responsible for their overall 
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beneficial effects in some patients. These effects may include actions on wider 
systems in the body including the peripheral and central nervous system, as 
well as a possible placebo effect of receiving an injection. Furthermore, when 
glucocorticosteroids are administered together with a local anaesthetic agent, it 
is also possible that the actions of the local anaesthetic agent could also 
contribute to the overall beneficial effect. It is plausible that local steroid 
injections, containing local anaesthetic agents, modulate central pain 
processing, in part, by temporarily blocking afferent pathways, rather than 
purely through an anti-inflammatory effect of the steroid. Subacromial injections 
undertaken with only local anaesthetic have been shown to provide pain relief 
beyond the pharmacological action of the drugs used, and have comparable 
outcomes to patients receiving injections containing local anaesthetic and 
glucocorticostreoid (Murphy and Carr 2010, Ekeberg et al, 2009, Alvarez et al, 
2005, Akgün et al, 2004, Vecchio et al, 1993).   
Although local steroid injections are widely used, and seen as an important and 
effective treatment option, within the overall management for some patients with 
shoulder pain, it could be argued at times a local steroid injection may not be 
the most appropriate choice or only option. However, the use of alternative 
injection therapy approaches in the management of shoulder pain, such as local 
anaesthetic alone or SSNB injections, although showing some evidence for 
effectiveness in chronic shoulder pain, are not widely reported in the literature 
(Chang et al, 2016, Bryceland et al, 2015, Buchbinder et al, 2013, Littlewood et 
al, 2012, Chan and Peng 2011, Hanchard et al, 2011, Murphy and Carr 2010).  
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Peripheral nerve block injections 
Peripheral nerve block injections have been shown to provide prolonged pain 
relief for patients with chronic pain, including patients with peripheral neuralgia 
(Arnér et al, 1990), headaches (Gale et al, 2002, Rothbart et al, 2000) as well 
as wider musculoskeletal conditions (Jankovic & Peng 2015) including shoulder 
pain (Chan and Peng 2011) although the mechanism that produces its 
prolonged effect on pain perception is unknown.   
A peripheral nerve block injection involves the blockade of a specific peripheral 
nerve or nerves by a nerve blocking agent. In clinical practice, local anaesthetic 
agents are often used in combination with a glucocorticosteroid (Shanthanna et 
al, 2016). For a long lasting local anaesthetic agent such as 0.25% 
Bupivacaine, the duration of nerve blockade is reported to be from 2.5 to 20 hrs 
(Jankovic 2008). Blockade of sodium channels within the nerve cell membrane, 
results in the transient interruption of propagation of nerve impulses along the 
nerve axon, thereby modulating afferent input into the CNS from the periphery 
and efferent input from the CNS to the periphery.   
The use of glucocorticosteroid combined with local anaesthetic agents, 
administered within nerve block injections is widely reported in the literature 
(Shanthanna et al, 2016, Chan and Peng 2011). However, the rationale for 
adding glucocorticosteroid to a local anaesthetic agent for a nerve block 
injection is not clear and has not been widely investigated. The actual 
mechanism by which the addition of glucocorticiosteroid improves the efficacy 
of a nerve block injection may be related to prolonging the duration of nerve 
blockade through its local actions on the nerve, its wider anti-inflammatory 
 18 
properties and systemic effect that reaches the local tissue, its effects on the 
CNS or even placebo (Shanthanna et al, 2016).  
The mechanisms by which nerve block injections, with or without the addition of 
glucocorticosteroid, provide prolonged pain relief, beyond the pharmacological 
duration of action of the drugs used is unknown. In patients with chronic pain, 
especially with a sensitised pain system, it may be hypothesised that 
temporarily blocking afferent impulses into the spinal cord, could result in a 
‘resetting’ of this sensitised pain state. By blocking this input, even temporarily, 
may modulate pain activation thresholds and revert the pain system to a lower 
level of activation. Basbaum (2009) argued that prolonged pain relief, following 
peripheral nerve blocks, may be the result of a transient quieting of central 
sensitization that is driven by ongoing aberrant peripheral nerve activity. 
The Suprascapular Nerve (SSN) 
The SSN is a mixed motor and sensory nerve originating from the upper trunk 
of the brachial plexus of C5-C6 nerve roots and in 15-22% of cases also the C4 
nerve root (Vorster et al, 2008) and is reported to supply up to 70% of the 
sensory innervation to the shoulder joint complex, as well as supplying motor 
innervation to both the supraspinatus and infraspinatus muscles (Chan and 
Peng 2011).   
The SSN travels from the brachial plexus, through the posterior triangle of the 
neck and passes through the suprascapular notch of the scapular into the 
suprascapular fossa (Blum et al, 2013). The accompanying suprascapular 
artery and vein tend to cross above the transverse ligament (Bigliani et al, 
1990). Once entering through the suprascapular notch, the main trunk of the 
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SSN travels along the floor of the suprascapular fossa before it curves around 
the lateral border of the scapular through the spinoglenoid notch to supply the 
infraspinatus muscle (fig.1). Although anatomical variation does exist, generally 
the lateral floor of the supraspinatus fossa contains all the sensory components 
of the SSN that supply the coracoclavicular ligament, coracohumeral ligament, 
acromioclavicular joint, subacromial bursae and posterior glenohumeral capsule 
(Blum et al, 2013; Dean et al, 2013, Ebraheim et al, 2011; Vorster et al, 2008; 
Ide et al, 1996; Aszmann et al, 1996). Thus, the location of the sensory 
component of the SSN, lying on the floor of the suprascapular fossa, provides 
specific access for needle placement that allows delivery of the drug close to 
the SSN. Blockade of the SSN has the potential to modulate afferent and 
efferent pathways that may reduce symptoms in the management of shoulder 
pain.  
 
Fig 1. Suprascapular nerve and its branches of the left shoulder. The superior articular branch (Br. SA) 
supplies the coracohumeral ligament, subacromial bursa, and posterior aspect of the acromioclavicular 
joint capsule. The inferior articular branch (Br. IA) supplies the posterior joint capsule. Br. IS, branch to the 
infraspinatus muscle; Br. SS, branch to the supraspinatus muscle. (Huntoon et al, 2011).  
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Suprascapular nerve block (SSNB) injections 
The use of SSNB injections for the treatment of shoulder pain was first reported 
in the literature by Wertheim and Rovenstine (1941). The procedure was 
reported to be ‘useful as an adjunct in the treatment of chronic shoulder pain’ 
and to enable other treatments such has ‘traction, manipulation and massage to 
be applied to a painful shoulder’ (Wertheim and Rovenstine 1941 p.541). A 
recent meta-analysis on the effectiveness of SSNB’s reported that SSNB 
injections were an effective treatment option for patients with chronic shoulder 
pain (Chang et al, 2016) and a recent narrative review by Chan and Peng 
(2011) reported that SSNB injections were effective for short term pain relief 
and improvements in shoulder function in a variety of shoulder problems 
including arthritic conditions, rotator cuff disease and frozen shoulder. Recent 
reviews of the management of shoulder pain report SSNB injections were 
reported as ‘likely to be beneficial’ in patients with glenohumeral joint disease 
including patients with frozen shoulder (Favejee et al, 2011, Murphy and Carr 
2010). Furthermore, a National Institute for Clinical Excellence (NICE) 
accredited commissioning guide reported that SSNB injections were a treatment 
option that may be considered within secondary care, for patients with 
subacromial pain, that were not appropriate for surgery (Kulkarni et al, 2015, 
Kulkarni & Rees 2015).  
A number of research studies have been published investigating the 
effectiveness of SSNB injections. A comprehensive literature search was 
undertaken within electronic data bases AMED, CiNAHL, MEDLINE, and 
Embase from the year of inception to March 2016 (see appendix 1). Twenty-
four studies investigating the effectiveness of SSNB injections were found. 
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These studies are presented below in Table 1. Although many of these studies 
report that SSNB injections may be an effective treatment option for some 
patients with chronic shoulder pain, there are a lack of randomised placebo 
controlled trials to provide robust evidence in this area. Many studies are 
observational and have been undertaken on heterogeneous populations. It is 
therefore unclear which shoulder conditions respond well to SSNB injections. A 
variety of different injection therapy approaches and drugs are also used in the 
published literature. Some studies combined SSNB injections with 
physiotherapy and exercises whilst others investigate SSNB as a stand-alone 
treatment. The data from published studies is captured in table 1 below and 
described in the following sections.  
Table 1. Data extracted from studies investigating effectiveness of SSNB injections.  
Study Title Subjects Design Outcome 
Measures 
Findings 
1.Mitra, P. K. and 
Bhattacharya, D. (2016) 
'Comparison of Clinical 
Effects of Ultrasound 
Guided Suprascapular 
Nerve Block and Oral 
Pregabalin Versus 
Suprascapular Nerve 
Block Alone for Pain Relief 
in Frozen Shoulder'. Indian 
Journal of Pain 30 (1), 49  
Frozen 
shoulder 









US guided SSNB & oral 
pregabalin vs US guided 
SSNB alone.  




9ml 0.25% Bupivacaine) 
 75mg Pregabalin @ 




Baseline, Weeks 4, 
6 &12 
Both gps ss 
improvements in pain 
and ROM @ 4, 6 & 
12 weeks. 
 
ss additional benefit 
with pregabalin both 
OM @ week 4,6 & 
12 
2.Chansoria, M., Das, G., 
Mathankar, N., Chandar, 
D., Vyas, N., and 
Upadhyay, S. (2015) 'A 
Preliminary Study of a 
Novel Technique of 
Suprascapular Nerve 
Block in Treating Chronic 
Shoulder Pain'. Indian 









M30 F 10 
Observational. 
 






Non validated pain 
score 1-4 
Week 1& 4 
ss improvements @ 
weeks 1 and 4 all 
outcome measures 
3.Dorn, C., Rumpold-
Seitlinger, G., Farzi, S., 
Auer, J., and Bornemann-
Cimenti, H. (2015) 'The 
Effect of the Modified 
Lateral Suprascapular 
Block on Shoulder 
Function in Patients with 
Chronic Shoulder Pain'. 
Anesthesiology and Pain 






Cal tend 6 
Rot cuff 6 
Arthrosis 2 
duration of 
Sx?   
n20 
Age 52 




One injection and 
observe. 
 
5ml 0.5% ropivacaine. 
 
Indirect approach- Feigl. 
 
CMS 
Pain NRS (VAS) @ 
rest and on mvt. 
 
1hr and 24 hrs post 
injection. 
All outcomes sig 
improvement to 
baseline at both 1hr 
and 24 hr.  
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Study Title Subjects Design Outcome measures Findings 
4.Klc, Z., Filiz, M. B., Cakr, 
T., and Toraman, N. F. 
(2015) 'Addition of 
Suprascapular Nerve 
Block to a Physical 
Therapy Program 
Produces an Extra Benefit 
to Adhesive Capsulitis: A 
Randomized Controlled 
Trial'. American Journal of 
Physical Medicine & 
Rehabilitation / 
Association of Academic 


















SSNB (followed by 
physiotherapy) Vs 
physiotherapy alone.  
Physiotherapy included 
15 sessions. 5 days a 
week for 3 weeks. 
Hot packs, tens, US, 
manual therapy, Ex’s, 
HEP. 






Baseline, 3 & 7 
weeks.  
Both gp’s showed ss 
improvements in  
BPI-SF and CSS at 3 
& 7 weeks compared 
to baseline. 
SSNB plus 




in the CSS, and in 4 
domains of the BPI-
SF at week 3 and 3 
domains of BPI-SF at 
7 weeks.  
No difference in CSS 
between gps at 7 
weeks.  
5.Bayram, K., Bal, S., Safa 
Satoglu, I., Kocyigit, H., 
Gürgan, A., Akcay, S., and 
Kazimoglu, C. (2014) 
'Does Suprascapular 
Nerve Block Improve 
Shoulder Disability in 
Impingement Syndrome? 
A Randomized Placebo- 
Controlled Study'. Journal 
















9ml 2% prilocaine & 






@ Baseline, 30 min, 
2/52 & 3/12. 
SSNB gp sig. 
improvement in pain 
and function @ 2/52 
& 3/12. 
6.El-Badawy, M. A. and 
Fathalla, M. M. (2014) 
'Suprascapular Nerve 
Block Followed by 
Codman's Manipulation 
and Exercise in the 
Rehabilitation of Idiopathic 
Frozen Shoulder'. 
Egyptian Rheumatology 














SSNB injection followed 
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SSNB injection techniques and approaches used in clinical studies 
A variety of injection therapy approaches and techniques have been used in 
published clinical studies, including both surface landmarked, nerve stimulator 
Electromyography (EMG) and image guided injections such has ultrasound 
(US), computerised tomography (CT) and fluoroscopy (Chang et al, 2016, 
Fenandes et al, 2012a, Fenandes et al, 2012b, Chen and Peng 2011).  
Anatomical landmarked approaches are the most common approach in the 
studies retrieved. The literature describes mainly two landmarked approaches; 
the direct approach and the indirect approach. The direct approach aims to 
guide the needle tip into the suprascapular notch to deliver the drug close to the 
SSN. The documented risks associated with using the direct approach were 
trauma to the SSN, suprascapular artery and vein, injection of bolus into a blood 
vessel, and pneumothorax (Fernandes et al, 2012b, Chan and Peng 2011). The 
direct approach was reported to have the greatest potential serious risk of 
causing a pneumothorax due to the trajectory of needle and possibility of the 
needle passing through the notch into the thoracic cavity (Parris 1990). 
However, from reviewing the published clinical studies presented in table 1. no 
cases of pneumothorax were reported.   
In contrast to the direct approach, the indirect approach does not aim to deliver 
the drug within the suprascapular notch. After entry though the skin the needle 
is directed perpendicularly and towards the lateral half of the floor of the 
suprascapular fossa, the drug is then delivered to diffuse and flood the area 
around the SSN (Chen and Peng 2011). The indirect landmarked approach was 
the approach used in eleven out of sixteen studies that utilised a landmarked 
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anatomical approach (Dorn et al, 2015, Bayram et al, 2014, El-Badawy and 
Fathalla 2014, Salgia et al, 2014, Shanahan et al, 2012, Di Lorenzo et al, 2006, 
Dahan et al, 2000, Shanahan et al, 2003, Karatas and Meray 2002, Jones and 
Chattopadadhyay 1999, Rowlingson and Arasi 1986). The indirect landmarked 
approach was found to be an effective and safe approach in a double blind, 
RCT, by Shanahan et al, (2003) that compared SSNB injection (10ml 0.5% 
Bupivacaine & 40mg Depomedrone) to SSNB placebo injection (saline) in 
eighty-three patients (108 shoulders) with chronic shoulder pain. Furthermore, 
the same authors reported the indirect landmarked approach to be safe and 
effective, based on the findings of a large observational cohort study of over 
one thousand injections (Shanahan et al, 2012).  
Various guided techniques are reported in the literature, such has CT 
(Schneider- Kolsky et al, 2004, Shanahan et al, 2004) fluoroscopy (Kang et al, 
2012, Ozkan et al, 2012), EMG (Karatas and Meray 2002) and ultrasound (Mitra 
and Bhattacharya 2016, Lotero et al, 2013, Gorthi et al, 2010). Shanahan et al, 
(2004) undertook a RCT in seventy-seven patients and demonstrated that the 
use of CT guidance provided no additional benefit to a landmarked approach. 
However, on reviewing the intervention method, the CT group received a 
smaller dose (3ml of 0.5% bupivacaine) compared to the unguided landmarked 
group (10ml of 0.5% bupivacaine).  
Gorthi et al, (2010) under took a RCT in fifty patients comparing US guided 
SSNB to a landmarked approach. They reported that although both groups had 
statistical significant improvements in pain and function at 1 month, the US 
group had statistically significant greater improvements compared to the 
landmarked group. However, the above study has limitations due to the low 
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number of participants recruited, the poorly defined study population and the 
potential effects of placebo due to lack of blinding of participants and 
researchers.  
Although US guided SSNB injections were reported to be more effective and 
the preferred option in a meta-analysis by Chang et al, (2016) these 
recommendations appear to be based upon the results of two trials investigating 
the effectiveness of pulsed radiofrequency (prf) denervation of the SSN (Wu et 
al, 2014) and continuous SSNB with an indwelling catheter (Abdelshafi et al, 
2011) not a SSNB injection.  
Therapeutic agents used for SSNB injections 
A variety of different local anaesthetic agents combined with or without steroid 
have been used for SSNB injections within published clinical studies 
(Fernandes et al, 2012a, Fernades et al, 2012b, Chan and Peng 2011). The 
addition of steroid to local anaesthetic was reported in fourteen clinical studies 
(Mitra and Bhattacharya 2016, Chansoria et al, 2015, Klc et al, 2015, Bayram et 
al, 2014, El-Badaway and Fathalla 2014, Salgia et al, 2014, Ozkan et al, 2012, 
Shanahan et al, 2012, Schneider- Kolsky et al, 2004, Shanahan et al, 2004, 
Shanahan et al, 2003, Jones and Chattopadhy 1999, Vechio et al, 1993, Emery 
et al, 1989). However, findings from nine further studies indicate that using local 
anaesthetic alone may provide effective pain relief and the addition of steroid 
may not be necessary (Dorn et al, 2015, Lotero et al, 2013, Kang et al, 2012, Di 
Lorenzo et al, 2006, Taskaynatan et al, 2005, Karatas and Meray 2002, Dahan 
et al, 2000, Gado and Emery 1989, Rowlingson and Arasi 1986).  Only one 
study was found that compared using local anaesthetic alone to using local 
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anaesthetic combined with steroid (Gado and Emery 1989). Gado and Emery 
(1989) recruited twenty-nine patients with RA with chronic bilateral shoulder 
pain. For each patient, their worst shoulder was identified and then randomized 
to receive a SSNB injection with local anaesthetic alone (2ml 0.5 % 
Bupivacaine) or a SSNB injection with local anaesthetic combined with steroid 
(2ml 0.5% bupivacaine & 40mg prednisolone). Of note all participants received 
both injections with their worst shoulder randomized to different treatment 
groups. The findings indicated that the addition of steroid provided no additional 
benefit in pain relief or function at weeks 1, 4 and 12. The potential systemic 
effects of receiving a dose of steroid in the contralateral shoulder were 
dismissed by the authors based on the assumption that the level of absorbed 
steroid would be too low to have a systemic effect and improve symptoms in the 
contralateral shoulder.  
No studies were retrieved investigating the optimal drug dosage or volumes for 
a SSNB injection. A study in cadavers by Feigl et al, (2007) reported that a 
volume of 5ml may be adequate to flood the lateral suprascapular fossa. In 
addition, a further study in surgical patients reported that a volume of 10ml is 
sufficient to flood the suprascapular fossa (Jerosch et al, 2008).  
Patient sub-groups and SSNB injections 
Clinical studies investigating SSNB injections have been undertaken in a variety 
of patient groups with chronic shoulder pain, including non-specific shoulder 
pain (Chansoria et al, 2015, Salgia et al, 2014, Schneider-Kolsy et al, 2004, 
Gorthi et al, 2010, Taskaynatan et al, 2005), frozen shoulder (Mitra and 
Bhattacharya 2016, Klc et al, 2015, El-Badawy and Fathalla 2014, Ozkan et al, 
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2012, Karatas and Meray 2002, Dahan et al, 2000, Jones and Chattopadhyay 
1999), subacromial impingement / rotator cuff disease (Bayram et al, 2014, Di 
Lorenzo et al, 2006, Vecchio et al, 1993) and RA with degenerative 
glenohumeral joint disease (Shanahan et al, 2004, Shanahan et al, 2003, Gado 
and Emery 1993, Emery et al, 1989). In addition to specific sub groups, other 
studies have investigated the effectiveness of SSNB injections in heterogenous 
groups of patients with chronic shoulder pain, that included patients diagnosed 
with frozen shoulder, degenerative glenohumeral joint disease, subacromial 
pain and non-specific shoulder pain (Dorn et al, 2015, Lotero et al, 2013, 
Shanahan et al, 2012, Kang et al, 2012, Rowlingson and Arasi 1986).  
Physiotherapy and shoulder exercises after SSNB injection 
No studies were retrieved that investigated the application of physiotherapy 
intervention following SSNB injections. Kilic et al, (2015), however 
demonstrated that SSNB injections added to a program of physiotherapy was 
more effective than physiotherapy alone, in terms of pain relief and improved 
function, for patients with frozen shoulder at weeks 1, 4 and 12 post injection. A 
number of studies reported that shoulder exercises were advised post SSNB 
injection although the actual application of the exercises and physiotherapy 
treatments in studies were not widely reported (Mitra and Bhattacharya 2016, 
Kilic et al, 2015, Ozkan et al, 2012, El-Badawy and Fathalla 2014, Mitra et al, 
2009, Di Lorenzo et al, 2005, Dahan et al, 2000, Jones and Chattopadhyay 





Summary of published literature on SSNB injections 
The published literature indicates that SSNB injections may be an effective 
treatment option for some patients with chronic shoulder pain irrespective of the 
underlying shoulder condition or disease. Considering that the SSN supplies 70-
80% of the sensory innervation to the shoulder complex, it may not be 
surprising that SSNB injections offer pain relief for different conditions affecting 
the shoulder complex.  Although different guided and landmarked approaches 
are described in the literature no specific approach has been shown to be more 
effective. The indirect landmarked approach is the most commonly used 
approach in published studies and is reported to be easily performed, effective, 
safe and acceptable for patients (Shanahan et al, 2012). A variety of local 
anaesthetic agents used alone or in combination with steroids have been used 
in clinical studies. However, no specific drug or combination of drugs have been 
proven to be any more effective. Furthermore, the addition of steroid to local 
anaesthetic may offer no additional benefit, however the only study investigating 
this may have methodological flaws with low participant numbers and each 
treatment group receiving a dose of steroid in the contralateral shoulder (Gado 
and Emery 1989). 
No studies have been undertaken regarding the timing of application of SSNB 
injections in patients with shoulder pain to investigate if SSNB injections are 
effective in patients before chronicity is established. The long-term benefits of 
SSNB injections are unknown and the optimal frequency of repeat injections 
has not been investigated. SSNB injections combined with physiotherapy may 
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be beneficial for patients with frozen shoulder (Kilic et al, 2015) however there is 
a lack of quality research investigating the optimal application of SSNB 
injections combined with physiotherapy interventions for different shoulder 
conditions. Although the literature indicates that SSNB injections may be an 
effective treatment option for some patients with chronic shoulder pain, its 









Research question: What are the experiences and views of clinicians regarding 
the use and role of suprascapular nerve block injections in the non-
surgical management of shoulder pain? 
Aim:  
• To explore the experiences and views of rheumatologists, pain 
consultants and physiotherapists on the role and use of SSNB injections 
in the non-surgical management of shoulder pain. 
Objectives: 
• To explore and gain an understanding of how clinicians decide which 
patients with shoulder pain are selected to receive a SSNB injection. 
• To identify and describe the approaches, techniques, drugs, dosages 
and frequency of injection used by clinicians in the administration of 
SSNB injection and their reasons for choice. 
• To explore how clinician’s determine if SSNB injections are effective.  
• To explore clinicians’ views on the role of SSNB injections combined with 
other adjunct treatment modalities (for example physiotherapy, shoulder 
exercises and other injections). 
• To identify any areas of clinical uncertainty, gaps in knowledge and areas 







Literature Review  
Search strategy 
The aim of this literature review was to identify research relating to the use and 
application of SSNB injections in clinical practice, in order, to synthesise 
existing knowledge, and to identify any gaps in knowledge, in this topic area. 
Both qualitative and mixed-methods / survey studies were considered for 
inclusion, as it was felt these research approaches may reveal important 
knowledge around the subject area. Due to the exploratory nature of the 
research question, it was also felt appropriate to consider wider published 
research, relating to the use and clinical application of other nerve block 
injections, used in the treatment of musculoskeletal pain, that may provide 
relevant and important background knowledge in this area. In addition, 
qualitative research studies, that explored clinicians’ views and experiences of 
managing shoulder pain were also considered. The methodological approach 
and methods used in the included studies, were reviewed to inform the authors 
own research approach. Searching for and identifying appropriate qualitative 
research can be challenging due to the subjective nature of qualitative research 
study titles and variation and inconsistency of indexing qualitative research 
studies (Cooke et al, 2012). A literature search was initially conducted in March 
2016, with a more extensive search repeated in January 2017, due to major 
amendments being required from viva examiners. 
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In order, to capture as many relevant articles as possible, the SPIDER tool, 
presented by Cooke et al, (2012), was utilised as a framework to identify the 
most appropriate key words for the literature search (Table 2). 
 
Table 2.  SPIDER search strategy framework. (Cooke et al, 2012).  
Articles listed in electronic databases AMED, CiNAHL, MEDLINE, Embase were 
searched through accessing NHS Evidence, Journals and Databases. Articles 
were limited to English language. No date limit was applied, as it was 
anticipated a paucity of published literature would be available on the subject 
matter. Reference lists of retrieved articles were screened for additional 
literature and articles that were not identified from within the electronic search.  
 
Some materials have been removed from this thesis due to Third Party Copyright. The unabridged version of the thesis 
can be viewed at the Lanchester Library, Coventry University. 
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Search results 
Nine hundred and seventy-two articles were initially identified from the search 
undertaken in January 2017, using the key words presented in table 2. These 
nine hundred and seventy-two articles were screened by title and abstract. Nine 
hundred and fifty-five articles were excluded at this point as they were not 
associated with the clinical application of nerve block injections in clinical 
practice or explored clinician’s experiences or views on the management of 
shoulder pain.  
Seventeen articles were identified from title and abstract screening as possibly 
being associated with the application and use of nerve block injections in clinical 
practice or explored clinician’s experiences and views on the management of 
patients with shoulder pain. These seventeen studies were retrieved in full text 
and were screened in more detail for consideration within this review. Table 3 
below shows the study selection process that was followed. Data from the 
seventeen full text studies retrieved was extracted and presented in table 4.  
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Table 3. Search strategy and study selection process. 
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Table 4. Data extraction table. Full Text articles screened.  
Author Title Participants Methods Relevant Findings 
Hanratty et al 
(2016) 
Physical Therapists’ 
perceptions and use of 









Types of exercise.  
Manual therapy & 
taping.  
Kraal et al, 
(2016).  
 
How to treat a frozen 
shoulder? A survey 
among shoulder 
specialists in the 
Netherlands and Belgium 
Shoulder 
surgeons n100 
Survey In painful stage 80% 
consider LSI, NSAIDs, 
Advice & Education.  
Thawing phase 68% 
consider Physio 
Bryceland et al 
(2015) 
Current UK practices in 





Survey 82% consider Physio 
and LSI 
Littlewood et al 
(2015) 
Understanding the 
barriers and enablers to 
implementation of a self-
managed exercise 















surgical treatment of 
frozen shoulder. Survey 





Survey Based on stiffness 
stage. 
68% consider PT and 
54 % consider LSI 
before surgery 
Littlewood et al, 
(2014) 
Patients with rotator cuff 
tendinopathy can 
successfully self-
manage, but with certain 





Interviews No relevance 
 
Related to a treatment 
protocol 
Ottenheijm, R. 
P., et al, (2014)  
GP’s perspectives on the 
diagnostic work-up in 
patients with shoulder 
pain: a qualitative study. 






Surgical Referral Criteria 
for Degenerative Rotator 




Delphi  Consensus set at 80%  
 
75% consider Physio & 





Management of Shoulder 
Pain in Comparison with 
Rheumatology 
Expectation of Care and 




GPs n611  
Rheumatologists 
n64 
Survey Multiple treatments 
Physio, LSI guided LSI 
& SSNB inj. 
 
10% Rheum consider 
SSNB in later stage FS. 
Randelli et al 
(2012) 
Current practice in 
shoulder pathology: 
results of a web-based 
survey among a 





Survey Multiple conservative 
management  
 
Physio, LSI, Hyaluronic 
acid 
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Hanchard et al 
(2011) 
A questionnaire survey 
of UK physiotherapists 






Survey Multiple physio Rx 
80% consider LSI  
Littlewood et al 
(2012) 
Rotator cuff disorders: a 




Survey Multiple Physio Rx’s   
30% consider LSI.  
Dennis et al, 
(2010) 
Managing idiopathic 
frozen shoulder: a survey 
of health professionals’ 







Survey Early stage Physio 
33%,  
18% LSI  
 
late stage  
Physio 19%  
LSI 12% 
 
May et al 
(2008) 
Expert therapists use 
specific clinical 
reasoning processes in 
the assessment and 
management of patients 
with shoulder pain: a 





Delphi No relevance 
 
Related to model of 
clinical reasoning 
Dunn et al 
(2005) 
Variation in Orthopaedic 
Surgeons Perceptions 
about the Indications for 
Rotator Cuff Surgery. 
Surgeons 
n539 
Survey 79% consider physio 
prior to surgery  
73% consider LSI prior 
to surgery 
Johansson et al 
(2002) 
A combination of 
systematic review and 













Johansson et al 
(1999) 
Attitudes toward 
management of patients 
with subacromial pain in 










No studies exploring the views and experiences of clinicians on the use of 
SSNB injections in the non-surgical management of shoulder pain were found. 
Furthermore, no studies could be found exploring the views and experiences of 
clinicians on the use of nerve blocks in the management of wider 
musculoskeletal pain.  From the seventeen full text studies retrieved only one 
study was found which reported on the use and application of SSNB injections 
in clinical practice (Buchbinder et al, 2013). In addition, only one study was 
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retrieved that explored clinician’s views and experiences on managing shoulder 
pain and focussed on the use of exercise in the treatment of subacromial 
shoulder pain (Hanratty et al, 2016). Only two studies, Buchbinder et al, (2013) 
and Hanratty et al, (2016) were selected for inclusion in this literature review.  
Discussion of selected studies 
Buchbinder et al, (2013) undertook a survey questionnaire with Australian 
General Practitioners (GP’s) and Rheumatologists in the year 2009. A total of 
six hundred and eleven GPs and seventy Rheumatologists participated in the 
survey. Clinicians were surveyed on the management approaches they would 
advocate for patients with four different shoulder conditions when treated in 
primary care. The survey findings highlighted that clinicians considered a variety 
of different management approaches for patients with shoulder pain, including 
general advice on self-management, referral to physiotherapy, prescription of 
medication, administration of glucocorticoid injection into the; subacromial 
space, glenohumeral joint, acromioclavicular joint, area of maximum 
tenderness, referral for ultrasound guided injection, referral for arthrographic 
distention (hydrodilatation) and SSNB injection. The use of SSNB injection was 
consider by very few clinicians for the different vignettes. Clinicians preferred 
choice of injections for the different clinical vignettes are presented in table 5 to 






Table 5. Vignette – A 77 year-old female patient with a six-week history of rotator cuff tendinopathy. 
Choice of injection GP’s n = out of 613 n (%) Rheumatologists n= out of 64 n 
(%) 
SSNB injection 1 (<1) 0 (0) 
Subacromial LSI 208 (34) 44 (69) 
Glenohumeral joint LSI 15 (2) 2 (3) 
Acomioclavicular joint LSI 10(2) 2 (3) 
Area of maximum tenderness LSI 51 (8) 0 
Image guided LSI 145 (24) 21 (33) 
Hydrodilatation 9 (2) 1 (2) 
 
Table 6. Vignette - A 45 year-old patient with an acute rotator cuff tear. 
Choice of injection GP’s n = out of 609 n (%) Rheumatologists n= out of 59 n 
(%) 
SSNB injection 0 (0) 0 (0) 
Subacromial LSI 47 (8) 11 (19) 
Glenohumeral joint LSI 6 (1) 1 (2) 
Acomioclavicular LSI 9 (2) 1 (2) 
Area of maximum tenderness LSI 23 (4) 1 (2) 
Image guided LSI 62 (10) 7 (12) 
Hydrodilatation 5 (1) 0 (0) 
 
Table 7. Vignette - A 50 year-old female patient with a three-week history of frozen shoulder 
Choice of injection GP’s n = out of 612 n (%) Rheumatologists n= out of 59 n 
(%) 
SSNB injection 5 (1) 6 (10) 
Subacromial LSI 61 (10) 12 (20) 
Glenohumeral joint LSI 80 (13) 33 (56) 
Acomioclavicular LSI 6 (1) 0 (0) 
Area of maximum tenderness LSI 17 93) 0 (0) 
Image guided LSI 87 (14) 15 (25) 
Hydrodilatation 79 (13) 10 (17) 
 
Table 8. Vignette - A 50 year-old female patient with a three-month history of frozen shoulder. 
Choice of injection GP’s n = out of 606 n (%) Rheumatologists n= out of 59 n 
(%) 
SSNB injection 3 (1) 4 (7) 
Subacromial LSI 58 (10) 5 (9) 
Glenohumeral joint LSI 78 (13) 18 (31) 
Acomioclavicular LSI 5 (1) 0 (0) 
Area of maximum tenderness LSI 29 (5) 0 (0) 
Image guided LSI 106 (17) 6 (10) 
Hydrodilatation 115 (19) 24 (41) 
 
The findings from Buchbinder et al, (2013) indicate that from the sample of GPs 
and Rheumatologists who participated in their survey, undertaken in Australia in 
2009, only a small percentage of GPs (1%) and Rheumatologists (7-10%) 
considered SSNB injections as a treatment option for patients with shoulder 
pain, with frozen shoulder being the main condition they would consider using it 
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in. Clinicians considered using SSNB injections in both early and later stage 
frozen shoulder. The findings from Buchbinder et al, (2013) offers only minimal 
insight into the application and use of SSNB injection in clinical practice. The 
survey provided no information on the choice of drugs used by clinicians for 
SSNB injections or the injection technique / approach utilised by clinicians. The 
survey provided no indication on the frequency of SSNB injections given in 
clinical practice or whether SSNB injections are given as stand-alone 
treatments or combined with other interventions such has physiotherapy or 
shoulder exercises.  No further studies that provided information on the clinical 
application of SSNB injections were retrieved. No studies were found that 
explored the views and experiences of clinicians on the use of SSNB injections 
in the management of shoulder pain and only one study was retrieved that 
explored clinician’s views and approaches to managing shoulder pain in clinical 
practice (Hanratty et al, 2016).  
Although the use of injection therapy treatment did not feature or form part of 
the study findings by Hanratty et al, (2016), the study was reviewed to inform 
the authors own study methodology and research approach moving forward. 
Hanratty et al, (2016) undertook a focus group study, to explore physical 
therapist’s perceptions and use of exercise in the management of subacromial 
impingement syndrome with the aim of informing an exercise treatment 
protocol. Three focus group sessions were undertaken with physical therapists 
in Northern Ireland and the Republic of Ireland. Each focus group contained 
between six to eight experienced physical therapists, with at least five years 
post graduate experience, with the total number of physical therapists in all 
groups being 20.  
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The aims of Hanratty et al, (2016) were very specific to understanding clinician’s 
views and perspectives on the use of exercise therapy treating subacromial 
shoulder pain, therefore recruiting physical therapists with expertise in exercise 
therapy for their study, was appropriate. Hanratty et al, (2016) utilised a 
purposive sampling approach where participants were recruited based upon 
their experience of managing musculoskeletal conditions. All 20 participants 
held formal post-graduate training qualifications in manual therapy with at least 
five years clinical experience. Although utilising a purposive sampling approach 
is important to ensure that the participants recruited will be able to contribute to 
the topic area and provide the in-depth information required in exploratory 
research, limiting participation to one professional group or to participants with 
specific qualifications and experience arguable may also limit and introduce 
bias to the findings. Furthermore, including participants with a variety of clinical 
experiences and skills may provide additional concepts, ideas and themes that 
would not have be captured by limiting participation to a very selective sample. 
Hanratty et al, (2016) in fact recognised that including clinicians with different 
experiences may have enhanced their own study findings. Transferability of 
findings from qualitative research is an important factor that researchers and 
clinicians need to acknowledge and reflect upon. The views of participants from 
a very selective and specific group, recruited from one locality may not 
necessarily reflect the views of participants recruited from wider afield. Hanratty 
et al, (2016) recruited participants from Northern Ireland and the Republic of 
Ireland and recognised that widening the geographic region where their focus 
groups were undertaken, with a larger pool of potential participants to recruit 
from, may have strengthened the credibility of their findings.  
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Hanratty et al, (2016) report adopting a collaborative consensus approach with 
co-researchers when developing their focus group topic guide. Adopting a 
collaborative approach reduces the potential bias that could be introduced by 
any one researcher and improves the overall credibility and trustworthiness of 
the findings. Although a topic guide clearly needs to align with the overall aims 
of the study, it also needs to be flexible enough to give participants enough 
scope to explore their own ideas. This flexibility may allow new concepts and 
ideas to be revealed that were unknown to the researcher beforehand.  
Hanratty et al, (2016) reported utilising an experienced and unbiased focus 
group facilitator with little knowledge of the subject matter. Having an unbiased 
facilitator is important to allow participants the freedom to discuss their own 
ideas without undue pressure from the facilitator. There is however a counter 
argument to consider for using a facilitator with a good understanding of the 
topic area being discussed. A facilitator with some expertise in the area being 
discussed may be able to facilitate further discussions and clarification of 
participant comments and ideas that a facilitator with little knowledge of the 
subject matter could not.  
Hanratty et al, (2016) reported additional strategies that demonstrated 
dependability of their research approach and their findings. Focus groups were 
both audiotaped and videotaped. Non-verbal data, such has participant nodding 
in agreement to verbal comments and ideas formed part of the data analysis 
process. Verification and confirmation of the transcript against the recording by 
co-researchers and participants was also undertaken. Collaboration with co-
researchers on generating and developing themes through consensus meetings 
and final verification on themes with participants was also undertaken. Although 
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the focus group study by Hanratty et al, (2016) was not associated with the use 
of SSNB injections, the exploratory approach undertaken by the researchers 
offers a framework for the authors own study. The exploratory approach 
adopted by Hanratty et al, (2016) clearly facilitated the collection and generation 
of more in-depth information and data than what would have been captured 
from a survey study design.  
Conclusion 
Although SSNB injections may be an effective management approach for some 
patients with chronic shoulder pain (Chang et al, 2016, Chan and Peng 2011, 
Murphy and Carr 2010) this review has revealed a paucity of literature on the 
use and application of SSNB injections in clinical practice. The published 
literature does not provide any answers regarding the authors research 
question - What are the experiences and views of clinicians’ regarding the use 
and role of SSNB injections in the non-surgical management of shoulder pain? 
In fact, the literature appears to indicate that SSNB injections are not widely 
used in clinical practice for the non-surgical management of shoulder pain 
(Bryceland et al, 2015, Buchbinder et al, 2013, Littlewood et al, 2012, Hanchard 
et al, 2011).  
Only one study was retrieved capturing the use of SSNB injections in clinical 
practice; where a survey study was undertaken with a sample of GPs and 
Rheumatologists in Australia in 2009 (Buchbinder et al, 2013). The findings 
indicated that only a small percentage of the GPs and Rheumatologist surveyed 
considered using SSNB injections in the management of patients with shoulder 
pain, and for those that did, mainly in patients with frozen shoulder (Buchbinder 
et al, 2013).  A limitation of the survey may have been the limited clinical 
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vignettes proposed to clinicians. If more chronic shoulder conditions were 
presented, it is possible that more clinicians would have considered SSNB 
injections. Although survey research can provide an overview of clinical 
practice, the findings from Buchbinder et al, (2013) indicated that a survey study 
may not necessarily provide the right approach and flexibility needed to capture 
the in-depth and detailed information required to answer the research question 
in the author’s own study.  
Even though the study by Hanratty et al, (2016) provided no information on the 
views and experiences of clinicians regarding the use of SSNB injections in 
clinical practice, the research approach and focus group method utilised by 
Hanratty et al, (2016) provided a favourable framework to consider for use in 
the author’s own study. Research adopting and utilising this flexible exploratory 
approach may retrieve more detailed information, that is relevant to clinical 
practice, than a survey study approach could. Information gathered from 
clinicians may lay the foundation for future research in this area that could 
inform and guide clinical practice and ultimately improve outcomes for patients 





The literature review identified a paucity of research on the application and role 
of SSNB injections in clinical practice. The aim of this study was to explore the 
views and experiences of clinicians who currently use SSNB injections in the 
non-surgical management of shoulder pain, with the purpose of developing 
knowledge and informing future research in this area. At the start of this 
research project I had no conscious commitment to any specific philosophical 
research paradigm in which to address or align my research question. My 
approach to answering my research question evolved throughout the 
development of this thesis and MRes program. Although my own world views 
and experiences of research were more aligned with a ‘positivists’ world view 
and paradigm, I realised that searching for a single answer and objective ‘truth’ 
did not align with the fundamental purpose, principles and aims of the research 
question in this study. The in-depth information I sought from participants could 
not have been captured effectively through either a quantitative / experimental 
or a mixed method / survey approach. I believed a more flexible, qualitative 
approach, allowing for the generation of in-depth, rich understanding and 
exploration of participant experiences and views would be more appropriate.   
Although I recognised that my research aims broadly aligned within an 
overarching ‘interpretivist’ paradigm, I also recognised that the information I 
sought was ‘priori’ driven, using a topic guide designed to address my questions 
and research objectives. Therefore, the various methodological approaches 
commonly associated within an interpretivist paradigm, such as; grounded 
 50 
theory, phenomenology, ethnography and participatory action research would 
not necessarily provide the most appropriate methodological approach moving 
forward (Carpenter and Suto 2008, p60- 76).  Pragmatism, as a philosophical 
research approach, allows the researcher to conduct and undertake research in 
a manner that aligns with the purpose, aims and objectives of their study (Rorty 
1982). Pragmatism essentially provides a philosophical approach and 
framework that puts the aims and purpose of the research as the primary focus, 
so that the research question can be answered and addressed in the best way 
possible (Wahyuni 2012, Rorty 1982). A ‘pragmatic qualitative approach’, that 
provides a framework for presenting descriptive content from an interpretivist 
perspective, described by Savin-Baden & Major (2013 p.171) was therefore 
adopted for this study. The main focus, in this exploratory study, was to gain an 
in-depth understanding regarding the application of SSNB injections in clinical 
practice. I therefore felt it was important to seek the views and experiences of 
clinicians from different professional backgrounds who use SSNB injections. I 
felt that involving participants from different professional backgrounds would 
enhance this study and provide richer information around the topic area than 
participants from a single professional group. Initially both individual interviews 
and group interviews were considered for data collection methods. Both provide 
flexibility in data collection and a platform for participants to express their own 
views. It is however recognised that group interviews that involve participant 
discussion and interactions, have the potential to provide and generate richer 
data than one to one interviews (Offredy and Vickers 2010 p86-87, Redmond 
and Curtis 2009). For this reason, a focus groups method was chosen as the 
most appropriate data collection method for this study.  
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Ethical consideration 
Ethical approval for this study was granted by Coventry University Ethics 
Committee (P38675) and NHS R&D approval (16EDUC58) from Sandwell and 
West Birmingham Hospital NHS Trust R&D department (Appendix 2 and 3). All 
ethical research in the UK should adhere to the principles and standards set out 
in the Research Governance Framework (DOH 2005). All researchers involved 
in this study had previously undertaken Good Clinical Practice (GCP) prior to 
being involved in the study. The four underlying ethical principles that underpin 
research ethics and governance; respect for autonomy, non-maleficence, 
beneficence and justice (Beauchamp and Childress 2001) apply equally to both 
qualitative and quantitative research and were adhered to in this study. 
Written informed consent was obtained prior to the start of the focus group 
session from all participants (see appendix 4). Participants were made aware 
that participation was completely voluntary and they could withdraw at any time. 
A participant information leaflet (PIL) was emailed to all potential research 
participants during recruitment stage, several weeks before the anticipated 
focus group date. The PIL was also provided just prior to obtaining consent on 
the day of the focus group session on the 21st April 2016, that fully explained 
the aims of the study, that the study formed part of the researchers MRes 
programme and would be written up for hopeful publication in a peer-reviewed 
journal (Appendix 5 and 6). The topic under discussion in the focus group was 
not viewed as sensitive and it was not anticipated that participating in the focus 
group would pose any physical or emotion risk to research participants. 
However, it is recognised that one of the major concerns and risks undertaking 
a focus group study is confidentiality (Plummer D-Amato 2008a, Plummer D-
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Amato 2008b). To mitigate and manage this risk, research participants were 
made aware of their responsibilities to respect and maintain other research 
participants’ anonymity by the focus group facilitator when establishing ground 
rules prior to starting the focus group session. Furthermore, the informed 
consent form also clearly set out participants’ responsibilities in maintaining 
confidentiality and anonymity of the other study participants. In addition, 
transcription documents and reports that were available to people outside the 
research team, contained no participant identifiable information. Participant data 
within the transcripts were anonymised and assigned a participant label, i.e. 
(P.1).  All data was securely kept by the main researcher on a password 
encrypted USB memory stick during the study. All study data was kept within a 
locked file cabinet within the authors NHS Trust premises and will be destroyed 
after 5 years of the completion date of the study in adherence to Hospital NHS 
Trust R&D policy. No personal identifiable information of the research 






Sample and recruitment 
Both purposive and snowball sampling strategies were utilised to recruit 
research participants in this study. This is an accepted approach when 
recruiting participants for a focus group study, as this ensures that individuals 
capable of providing insightful answers to the research question are recruited 
(Plummer-D’ Amato 2008a). Specifically, physiotherapists, pain consultants, 
orthopaedic surgeons, interventional radiologists and rheumatologists, from 
across West Midlands NHS Trusts, who had expertise and experience of 
administering SSNB injections, in the non-surgical management of shoulder, 
were targeted.  From the author’s clinical experience these were the main 
professional groups undertaking SSNB injections at that time, in a clinical 
practice setting.  
A cross-section of clinicians were targeted as it was considered that participants 
from different professional backgrounds could offer different perspectives, 
experiences and views that would stimulate greater discussion and provide 
greater depth of information than a single professional group. Although, Morgan 
and Bottorff (2010) argued that variability in focus group member characteristics 
and group composition can negatively affect the group dynamics and limit 
discussion, it was felt that the recruitment strategy utilised for this focus group 
was an important aspect of the study, as members would be united by the 
commonality of the topic under discussion. Furthermore, one of the facilitator’s 
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roles was to ensure equal participant engagement and moderate any adverse 
dynamics within the group.  
The ideal size of a focus group when participants have expertise in the topic 
under discussion is usually between five and eight participants (Krueger and 
Casey 2015 p82). However, it is recommended that researchers allow for 
participant drop out prior to the start of the focus group and should therefore try 
to over recruit by 20% (Morgan 1997). Therefore, it was the authors aim to 
recruit up to twelve participants to allow for potential drop out. The inclusion and 
exclusion criteria for participants are presented below in table 9. 
Table 9. Inclusion and exclusion criteria. 
Inclusion Criteria Exclusion Criteria 
- Healthcare professional in the NHS 
- Recent experience of using SSNB 
- Consent 
- Able to attend a 1 hr focus group 
- English speaking 
- Time to validate themes and findings 
- Non English speaking 
 
Following ethical approval, clinicians locally who currently undertake SSNB 
injections in their clinical practice were contacted by email by the author and 
invited to participate in the focus group. An outline of the research project was 
provided in the email along with an attachment containing the PIL. The email 
advised potential participants that the study was completely voluntary and that 
the researcher would be happy to meet face to face to discuss and clarify any 
details of the study. The author also requested that the email be forwarded on 
to other colleagues in the West Midlands area, that the recipients were aware 
of, who undertake SSNB injections in their clinical practice. It was hoped that 
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this snowballing strategy would reach out to other potential participants’ 
unknown to the researcher. It was anticipated that clinicians working outside the 
West Midlands area would not have been able to attend a focus group at the 
researchers NHS Trust premises due to the logistics of arranging a focus group 
session for busy working clinicians. 
The initial response to the email was encouraging with three pain consultants, 
one rheumatologists, three interventional radiologists and three physiotherapists 
from within the researchers own NHS trust and one physiotherapist from a 
neighbouring NHS trust, all indicating, that if they were available, they would be 
willing to participate in the focus group. Unfortunately, no orthopaedic surgeon 
responded to the initial email. A second email was sent out, again without any 
response. At this point it was decided that any further emails or contact could be 
classed as coercion or pressurising potential participants to take part, so no 
further emails were sent.  
In total, eleven potential participants indicated they would like to participate in 
the focus group. Emails were sent to the eleven potential participants 
requesting and suggesting dates that would be suitable for them to attend. From 
email responses, it was decided that the focus group session would take place 
on the 21st April 2016 starting at 4.30 in the afternoon in a meeting room of a 
local hospital. 
Although eleven clinicians initially indicated that they could attend the focus 
group on the 21st April, unfortunately in the days leading up to the focus group 
session seven clinicians dropped out because of clinical commitments and 
personal reasons. In addition, immediately prior to the start of the focus group 
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on the 21st April, a phone call was received from another clinician advising that 
they were delayed but would join the focus group session when able.  
Thus, at the start of the focus group session only three participants were in 
attendance; two physiotherapists and one rheumatologist. Due to these low 
numbers and following discussion with the facilitator and group members, it was 
decided that myself, the main researcher should now participate in the focus 
group, rather than my original role as an observer / note taker. Fifteen minutes 
into the focus group the delayed participant arrived and joined the group. In total 
five clinicians participated in the focus group, three physiotherapists, one pain 
consultant and one rheumatologist. 
Focus Groups 
A focus group is a group interview involving discussion centred on a specific 
topic (Plummer-D Amato 2008a). Redmond and Curtis (2009) reported that 
focus groups allow participants the opportunity to explore each other’s 
reasoning and to listen to and consider other participant views that may 
stimulate further discussion on the chosen topic. It was considered that this 
would be a valuable aspect of the study considering the cross-section of 
clinicians involved. Furthermore, it is also recognised that focus groups are 
particularly suited to exploratory research where there may be an absence of 
theory (Stewart and Shamdasani 2014). This was a further reason and 
justification for utilising this method of data collection in this research project. 
Individual interviews were initially considered as a method of data collection and 
in hindsight, it is possible that more participants would have been available for 
individual interviews than a focus group session because of the flexibility of 
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arranging individual time slots. However, individual interviews would not have 
incorporated the positive group dynamics and interactions that focus groups can 
facilitate. Also, considering the time constraints of conducting and completing 
the write-up of this study (within one academic year) it was decided that a focus 
group would be a more realistic and achievable method of providing a rich data-
set within the confines of a MRes study.  
The Focus Group Session 
The focus group session took place on Thursday 21st April 2016 within the 
Research and Development department, of a local NHS Hospital. The focus 
group was conducted around a good size round table that could comfortably fit 
six people. Prior to the start of the focus group session the PIL was reissued 
again for each participant to review and discuss with the researcher as required. 
The background to the study was also presented by the author so that 
participants had the opportunity to discuss any queries. Informed consent was 
obtained immediately prior to the start of the session. It is recognised that the 
focus group facilitator plays a pivotal role, if a focus group session is to run 
smoothly and achieve its aims (Krueger and Casey 2015). At the start of the 
session the facilitator asked participants for introductions as not all members of 
the group were known to each other. The facilitator also ran through the 
process of the focus group and the ground rules that included responsibilities in 
terms of confidentiality and maintaining participant anonymity. They also 
encouraged openness and engagement. The facilitator also asked the 
participants to be mindful of talking over one another during discussions as this 
could cause issues and errors with transcription if different people talked at the 
same time. To mitigate audio-equipment failure, the focus group session was 
 58 
recorded on two digital devices. Questions from the focus group topic guide 
displayed in table 10 below, were presented to the group by the facilitator to 
stimulate discussion.  
Table 10. Focus Group Topic Guide 
Question Cues 
 
From your experience could you explain 
how you would decide which patients with 
shoulder pain receive a SSNB injection? 
 
Diagnostic criteria- (subacromial pain, frozen 
shoulder, rotator cuff tears). Does duration or 
severity of symptoms / pain form part of the 
decision-making process. Do you have any 
concerns with other shoulder injections that 
influences your decisions to consider a SSNB? 
Are there any age restrictions. If they have 
failed other treatments does this influence your 
decision? If a patient is awaiting surgery would 
you consider a SSNB? 
 
Once you’ve decided that a patient is 
appropriate for consideration of a SSNB 
injection what normally happens next?  
 
Consent. Patient information. Discussion of 
risks & contraindications. Advise following 
injection given. 
Could you describe what's involved when 
you perform a SSNB injection? 
 
How do you perform the procedure?  Patient 
position / injection approach / medication 
used. Positioning patient. Land marked or 
ultrasound guided injection. Techniques / 
aseptic. Drugs, dosages, volumes. Aftercare 
advice. 
How do you know if the injection has 
helped? 
 
Follow up. Outcome measures. Audit. 
 
Do you give your patients any advice 
following the injection? If so what? 
 
Rest. Exercise. Potential adverse effects. Wait 
after injection. What to do if concerned. How 
often would you repeat a SSNB injection? 
Do you teach any shoulder exercises or 
refer to any other services after the 
injection? 
 
Physiotherapy referral. Where. Concerns 
regarding delays. When to start exercises. 
Do you feel research is needed to answer 
any uncertainties or gaps in knowledge 
regarding SSNB injections?  
What kind of research would help in the 
future? Would further research help you 
decide which patients would benefit from a 
SSNB rather than subacromial injection / 
glenohumeral joint injection? 
 
Throughout the focus group session, the facilitator periodically summarised key 
components of the discussions and asked for verification from participants on 
specific points, thereby allowing further contributions from participants and 
allowing clarification of the key discussion points through paraphrasing. 
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Throughout the focus group the facilitator prompted and encouraged 
engagement from all participants in a sensitive respectful manner but was also 
able to distance themselves from the topic discussions, and did not overly 
influence the research participants, mitigating ‘moderator bias’ described by 
(Stewart and Shamdasani 2014 p94). The facilitator closed the focus group 
session once participants could not add anything further to the discussions. The 
focus group session lasted for 55 minutes. Participants were informed that once 
initial analyses had been undertaken, copies of the main themes would be sent 
for them to verify. All participants were in agreement with this. Immediately 
following the focus group session reflective field notes were captured by the 
author whilst the discussions and focus group dynamics were still fresh in their 
memory (Appendix 8).  The focus group recording was transcribed verbatim by 
a professional transcribing company with previous experience of transcribing 
focus group research within the NHS (Appendix 15). The transcript was 
returned from the transcribing company, in Microsoft word format, five days 







Jackson (1998) reported that there is no universally accepted method of data 
analysis for focus group research. Data analysis is described by Carpenter and 
Suto (2008) as the process of moving from narrative data to evidence based 
interpretations that are the foundation for published reports. The purpose of this 
study was to gain an in-depth understanding of clinician’s views and 
experiences of the role and use of SSNB injections in the non-surgical 
management of shoulder pain. Although the focus group study was driven by 
the focus group topic guide, which was constructed by the researcher and their 
supervision team, the fundamental underpinning principles and purpose of the 
study were that it was essentially exploratory in nature. It was therefore 
anticipated and expected that participants would reveal ideas and concepts that 
were not necessarily facilitated or drawn out by the questions in the focus group 
topic guide. Therefore, the data analysis process used needed to be flexible 
and reflect the wider views and experiences of the participants not just their 
responses to the topic guide questions.   
Thematic analysis, presented by Braun and Clarke (2006) was the chosen data 
analysis framework used within this study. It was felt that thematic analysis 
offered a structured and flexible approach and was an ideal starting place for 
the novice researcher. The chosen framework has six phases that were 





Table 11. Six phases of thematic analysis Braun and Clarke (2006) 
As stated in the previous sections, the focus group recording was transcribed 
verbatim by a professional transcribing company and was returned to the author 
five days after the focus group session (Appendix 15). During these five days 
the author was able to repeatedly listen to the digital recording and start to 
‘immerse’ themselves within the data. In addition, the reflective field notes 
(made immediately following the focus group session) were also considered at 
the same time as listening to the recording. Any interesting comments and 
Some materials have been removed from this thesis due to Third Party Copyright. The unabridged version of the thesis can 
be viewed at the Lanchester Library, Coventry University. 
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commonly occurring views and experiences were captured on additional notes 
during this period (Appendix 14). On reflection, even at this early stage, some 
initial subconscious analysis took place. Once the transcript was returned the 6 
phases of thematic analysis described by Braun and Clarke (2006) were 
followed. A more detailed account of the analysis in these 6 phases are 
provided in appendix 10 and 11. A systematic approach to coding was adopted 
throughout the whole transcript. This initial phase involved highlighting sections 
of associated text which were felt to be important, recurring, interesting and / or 
relevant to the purpose, aims and objectives of the study. The highlighted 
sections of text were tagged with codes. To gain a wider context of the coded 
data, the coded sections were then re-analysed through repetitive engagement, 
by re-reading the transcript, listening to the recording and reviewing any 
reflective comments captured on field notes. These codes were then extracted 
from the transcript and collated in tables (Appendix 11). At this point 
collaborative analysis was undertaken with members of the supervision team. 
The researcher initially met with their director of studies (DOS) (AG) to discuss 
codes and potential themes to facilitate the formation of thematic maps. These 
constructed maps aimed to provide the author with a visual ‘concept’ of the 
main themes and categories (Appendix 12). Further collaboration to verify 
themes took place with the focus group facilitator (JP). Once themes were 
constructed all the research participants were emailed to validate and verify that 
the main themes identified were a true and accurate reflection of their views and 




Trustworthiness and Rigor in research 
Demonstrating trustworthiness in qualitative research requires alternate 
strategies to those in quantitative research (Shenton 2004). Within qualitative 
research concepts of trustworthiness such as credibility, transferability, 
dependability and confirmability, described initially by Guba (1981), are often 
considered equivalent to the concepts; internal validity, external validity / 
generalisability, reliability and objectivity employed to minimise bias in 
quantitative research (Lincoln and Guba 1985) (see table 12 below).  




Some materials have been removed from this thesis due to Third Party Copyright. The unabridged version of the thesis 
can be viewed at the Lanchester Library, Coventry University. 
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Strategies adopted to establish trustworthiness in this study 
Various strategies were adopted in this study to demonstrate rigor and ensure 
trustworthiness of the findings. These strategies are presented in table 13. 
below and were described within the previous methods and data analysis 
sections.  
Table 13. Strategies adopted to demonstrate and ensure trustworthiness in this study 
Trustworthiness concept / criteria Strategy employed  
Credibility  • Use of accepted methods of data collection 
(Focus group).  
• Collaborative consensus approach during 
the development of the topic guide. 
• Use of an experienced facilitator in focus 
group methods. 
• Collaboration on coding and generation of 
themes with supervision team. 
• Member checking and validation of themes. 
• Reflexivity – position of researcher 
acknowledged, reflexive notes after focus 
group. 
Transferability • Purposive sampling.  
• Cross section of clinicians. 
• Presented thick descriptions of participant 
views in the findings. 
Dependability • Transcripts were compared to recording. 
• Data analysis process was transparent and 
clearly described.  
• Collaboration on coding and generation of 
themes with supervision team. 
• Member checking and validation of themes 
by participants. 
Confirmability • Member checking and validation of themes 
by participants. 
 
In qualitative research, it is widely recognised and accepted that the researcher 
themselves is an instrument within the research process (Carpenter and Suto 
2008). It may not be possible for the researcher to completely detach 
themselves from the research process in the same way that researchers remain 
objective within quantitative research. A researcher’s beliefs, experiences, 
views, values, goals and personal ambitions may all influence the way their 
research is constructed, designed, undertaken, analysed and presented within 
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qualitative research (Finely and Gough 2008). Reflexivity is the process which 
captures the position and background of the researcher. It captures the pre-
existing views, and facilitates self-critical analysis of the researcher throughout 
the whole research process (Savin-Baden and Major 2013). Reflexivity aims to 
provide a level of transparency to the reader to increase the trustworthiness of 
research findings (Savin-Baden and Major 2013, Finlay and Gough 2008, 
Shenton 2004).  
Reflexivity  
As stated in the background section of this thesis, this research project evolved 
from my own experiences, questions and uncertainties treating patients with 
chronic shoulder pain in clinical practice. I have used local steroid injections, 
within my physiotherapy management of patients with chronic shoulder pain, 
since 2007. In 2014 I also started to administer SSNB injections in patients with 
chronic shoulder pain, however as a service we have no criteria regarding 
which patients should be considered for a SSNB injection. Furthermore as a 
service we are also unsure on the most appropriate long term management of 
these patients. In my own practice I generally reserve SSNB injections for 
patients with chronic shoulder pain that have gained little benefit from previous 
local steroid injections and physiotherapy. 
The uncertainties and questions that I encountered in my clinical practice 
shaped and framed my research question and research approach in this MRes 
programme. My own view and belief is that injection therapy offers most 
patients’ with chronic shoulder pain short term benefit, however I believe more 
long term benefits can often be realised when injection therapy is used in 
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combination with shoulder exercises. Furthermore, I have often been faced with 
the dilemma of whether to repeat a local steroid injection in a patient with 
persistent shoulder pain, considering the potentially negative effect it may have 
on tendon tissue, balanced alongside the individual needs and views of the 
patient (Ackermann and Hart 2016 page 229 and 239, Dean et al, 2014a, Dean 
et al, 2014b, Coombes et al, 2010). I am however uncertain if and when a 
SSNB injection would be more appropriate in many of the patients I see that 
may request a repeat local steroid injection. 
Although my research is located within a qualitative paradigm, at the start of this 
research project I struggled to consolidate and articulate my philosophical 
stance or my chosen theoretical framework. I wanted to gain a wider and in-
depth understanding of the clinical application of SSNB injections. I wanted to 
know the ‘who’ and the ‘how’. I also wanted to explore the ‘why’. I used a ‘priori 
driven’ topic guide to facilitate discussion on the key topics associated with my 
research question and objectives, with a purposive sample.  Although at the 
outset of my project I was unconscious to my philosophical stance, I now feel a 
‘qualitative pragmatic approach’ best describes the theoretical framework I 
adopted (Savin-Baden and Major 2013 p. 60). On refection the theoretical and 
philosophical approach I apply in my every day clinical practice somewhat 
aligns with the approach I adopted in my research project. Although I have 
never previously acknowledged it, this most likely reflects my own world views 
and the belief that no single approach is right in clinical practice or research. My 
own belief is that the right approach is a flexible approach and the one that best 
suits the situation or problem in front of you.  
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One of the main problems associated with undertaking focus group research 
are uncertainties regarding participant numbers. Although six participants 
confirmed they were attending my focus group, at the start of the focus group 
session only three participants were present. This presented a dilemma as 
whether to continue with the focus group session or cancel. A decision was 
made to continue with the focus group due to it being unrealistic to rearrange a 
future date within the time constraints of completing my study, within one 
academic year, and the fact that clinicians had taken time out of their busy 
schedules to attend. As a result of the low numbers, and although I was the 
main researcher in the study, following discussion with the facilitator and the 
group, it was agreed and decided that I should now become a participant in the 
focus group. Although the reasons for participating in the group felt justified at 
the time, upon later reflection, the decision added a level of tension and conflict 
regarding my role as a researcher and participant.  
One of the main challenges and personal tensions that I encountered in this 
study centred around my involvement as a participant. Qualitative data analysis 
requires the researcher to immerse themselves within the data in order to 
explore and identify emerging themes. I wanted to and needed to demonstrate 
that the findings were an accurate representation of the views and experiences 
of the participants and not mine as the researcher. I was conscious and unsure 
of how these findings would be interpreted considering my conflicting role as a 
participant and researcher. Clearly the data that was collected and which I 
subsequently analysed was in part a product of my own personal experiences 
and views. I adopted a systematic approach to data analysis and used 
verification and collaboration to improve the trustworthiness of my findings. By 
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being transparent, in the reasons for the decision made, regarding my 
involvement as a participant and by documenting my own clinical experiences 
and views allows the reader to form a judgement on the credibility of my 
findings. The use of an experienced focus group facilitator who was able to 
ensure that discussions were not centred specifically around my own 
experiences and views also improved the credibility of the findings. Immediately 
following the focus group session, I made reflective notes capturing my 
thoughts on the dynamics and engagement of the group, along with what I felt 
were important and recurrent discussion topics (Appendix 8). These field notes 
were emailed to the facilitator for verification who agreed they were an accurate 
reflection of the group dynamics and topics discussed. Documenting immediate 
reflections also allowed me to consider some of my earlier concerns and 
anxieties around clinicians expressing their views and experiences openly, 
within a group of peers. I felt my previous concerns and anxieties were 
unfounded as participants openly engaged within the focus group.  
As an inexperienced researcher this study has provided me with the opportunity 
to develop my understanding of different research approaches and its 
application to different problems and questions. This learning experience has 
made me question my previous assumptions on what constitutes knowledge 
and on how knowledge is constructed. It has also made me reflect upon my 
own assumptions and beliefs especially in the way I view and interpret research 
and the way research informs and has the potential to inform my own clinical 
practice. In the future I recognise that a research reflective diary would improve 
my critical analysis of ‘myself’ and the way I approach, conduct, analyse and 





A total of five clinicians participated in the focus group. Three physiotherapists, 
one pain consultant and one rheumatology consultant. Participants experience 
of administering SSNB injections varied from 1 year to over 20 years, and from 
5 injections per year to 300 injections per year. The group included a mixture of 
community and secondary care based clinicians. The type of training 
undertaken in relation to administering SSNB injection varied from in-house 
training (within trust training) to specific formal training on ultrasound guided 
injections.  The participant profiles are presented below in table 14.  
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Group dynamics and interactions 
The focus group lasted for 55 minutes. All participants had equal opportunity to 
provide their views and experiences, without any one participant dominating the 
discussions. This was verified by the facilitator.  
The interactions and dynamics between the group members acted as a catalyst 
with clinicians providing rich and in-depth information and justified the focus 
group approach over one to one interviews. This group environment allowed 
clinicians to engage in discussion and conversations with each other that 
provided an added dimension.  
Throughout the focus group session there were many examples of group 
interaction and discussions between participants, where commonality and 
variability of practice was discussed. This arguably would not have been 
captured in one to one interviews. One such example, were discussions around 
the practice of one of the clinicians using local anaesthetic alone for SSNB 
injections compared to other clinicians using local anaesthetic and steroid 
(Appendix 15, line no. 412 – 427).  
Themes 
Using a thematic analysis framework three main themes were identified:  
 Patient Selection 
 The Intervention 
 Patient Management 
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The ‘Patient Selection’ theme is concerned with ‘who’ received the intervention. 
The theme captures the characteristics of patients that undergo SSNB 
injections within clinicians practice. It also captures the factors that clinicians felt 
were important in determining ‘who’ should be considered for a SSNB injection. 
‘The Intervention’ theme captures aspects and details of ‘how’ SSNB injections 
are carried out by different clinicians. The theme captures the technical aspects 
of the intervention, along with the clinician’s considerations for their choices. It 
also captures the drugs and dosages and factors influencing clinician’s choices. 
Potential risks were also discussed for the different approaches.  
The ‘Patient Management’ theme captures and describes aspects of patient 
pathways, any adjunct treatments that are involved in the patient care and 
clinician’s views on the overall management of patient’s care. Essentially this 
theme is concerned with overall patient management and the ‘what next’. 
Initially two further themes relating to ‘effectiveness’ and ‘future research’ were 
identified. However, from re-analysing the codes and transcript, and along with 
collaborative discussion with co-researchers, it was decided that the codes and 
categories grouped under ‘effectiveness’ were more aligned within the three 
main themes. After further exploration of the themes, it was also decided that 
the theme ‘future research’ was a cross-cutting theme and should be captured 
within each of the three main themes rather than a separate distinct theme all of 
its own.   
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Patient Selection; (who) 
The main observations made by clinicians, for patients that undergo a SSNB 
injection, were the long duration of symptoms that patient present with, at the 
point of being considered for a SSNB injection. Clinicians reported a number of 
factors that they considered were important when considering a SSNB injection 
in patients, such has failure to improve with other treatments, a SSNB injection 
has previously helped, a direct referral for a SSNB injection, the patient is 
unsuitable for surgery, the patient doesn’t want surgery and the associated risks 
of repeat local steroid injections. Clinicians identified key areas, within the 
theme of patient selection, where they felt future research was required 
including; identifying if SSNB injections are as effective as local steroid injection 
in specific shoulder conditions, and if SSNB injections are effective in patients 
with less established chronic pain. 
Initial patient evaluation forms part of the process, when determining which 
patients with shoulder pain are selected for a SSNB injection. This evaluation 
involves a clinical assessment and establishing previous management and 
treatments.  The clinicians view below, demonstrates, that a wide range of 
management options and factors may be considered when deciding if a SSNB 
injection is appropriate in a patient with shoulder pain. 
P4 ‘Personally when I've evaluated the patients clinically, I've obviously examined their 
 shoulder and I first establish what I feel the anatomical or the other explanation for 
 their shoulder is and I would personally divide up my pathologies into inflammatory 
 problems that are, I think, amenable to a different type of approach which is a steroid 
 injection or a mechanical problem that needs further investigation….’ (line 4-10). 
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Clinicians consistently identify ‘failure to respond to other treatments’ as a factor 
and ‘a long duration of symptoms’ as a common observation in patients who 
undergo a SSNB injection.  
 
These observations were further supported by the views and experiences of 
other clinicians when faced with patients who have not responded to any other 
treatment over a prolonged period of time. 
 
Clinicians report that it is not unusual for patients to have had symptoms for 6 
months at the point when they are considered for a SSNB injection. 
 
P2 ‘So it was a similar situation probably by assessing the patient and how far the pain is 
 there, that is one of the important factors, like if it has been there for ages and not 
 responded for physiotherapy, previous injections, manipulations….’ (line 21-24). 
P1 Yes, I think I'm in a similar position that the majority of patients I've chosen to have a 
 nerve block have, almost tried everything else first… (line 35-36). 
P4  ‘I personally reserve it for patients who have got more prolonged symptoms and have 
 failed to respond to other therapies…’ (line 91-92). 
P4 ‘all my patients would have had the symptoms ongoing for at least six months and been 
refractory to other modalities’ (line 100).   
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One clinician described a situation when they had concerns about undertaking 
repeated local steroid injections in patients with persistent shoulder pain. In 
these circumstances, they report they may consider administering a SSNB 
injection instead. 
 
At times, clinicians report they are presented with patients who are either not 
suitable for surgery, do not wish to consider surgery and have tried many other 
treatments without success. Some clinicians consider a SSNB injection a last 
resort. 
 
P1 ‘When you start to get a little bit concerned about the side effects of steroids locally, 
 maybe around the rotator cuff and potential weakening effects on tendon tissue, then 
 I've probably thought a suprascapular nerve block may be more appropriate’ (line 
 118-121) 
P5 ‘There are two group of patients I normally go for a suprascapular nerve  block.  
 Number one, the group is those patients who have had previous  shoulder surgery for 
 pain which hasn’t improved and their left where the surgeon doesn’t want to do 
 anything, so they are left with pain…… and another group of patients complains of 
 shoulder pain and the surgeons can't find anything’ (line 262-270). 
P3 ‘We tend to use it as almost like an injection of last resort, particularly in the patients 
 that have comorbidities which means they are unsuitable for surgery, so we will try 
 suprascapular nerve block if everything else has failed’. (line 30-33). 
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Clinicians also report times when SSNB injections have been specifically 
requested by a Consultant.  
 
Future Research: 
Even though at this time, SSNB injections appear to be reserved for patients 
with longstanding shoulder pain, clinicians felt that identifying if SSNB injections 
were effective in less established pain, was an area for future research.  
 
Another potential future research area discussed was comparing the 
effectiveness of SSNB injections to local steroid injections in specific shoulder 
conditions, such as patients diagnosed with subacromial pain. 
P2 ‘Depending on some of the consultants, they put them on the waiting list and 
then try the injection first and there will be a formal appointment in six months’ time and 
ask them to come for one or two injections and see how they are and if they are going to 
get better or not.’ (line 60-63) 
 
P1 ‘so we’re kind of labelling this injection used for chronic pain, long term persistent 
 pain and they’ve tried everything else first.  So I think some options are to do with 
 actually chronic pain being the only criteria. (734-736) 
P4 ‘you could probably make a good case for early intervention with this in other 
 shoulder pathologies, as a sort of an adjunct and would it add any value to the 
 outcome’ (line 738-740) 
 
P1 ‘I haven't come across studies that compare a nerve block to a subacromial injection 
 for subacromial pain. I've not seen any study. I've seen frozen shoulder’ (line 765-767). 
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Failed other treatments 
Unsuitable for surgery 
Risks with repeat local steroid injection 
Direct referral 
Last resort 
Doesn’t want surgery  
Duration of symptoms 
Categories 
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The intervention (how?) 
Clinicians describe a number of important aspects and considerations that are 
involved within the delivery of a SSNB injection. Different techniques and 
approaches were described, along with different drugs and dosages. The 
associated risks of the procedure are also described and discussed. Both 
surface land-marked and ultrasound guided approaches are used. In this focus 
group three clinicians use the indirect, surface land-marked approach, 
described in Chan and Peng (2011) and two clinicians utilise an ultrasound 
guided technique.  Clinicians that use ultrasound guided approaches use less 
drug volumes and have more confidence mitigating the potential risks of 
undertaking SSNB injections due to needle positioning and placement accuracy 
afforded by ultrasound guided techniques. Discussions in the focus group were 
generally centred around the benefits and risks of the different approaches used 
by clinicians when administering a SSNB injection. All clinicians tended to follow 
the same informed consent procedure, discussing the risks and benefits with 
the patient. Clinicians generally advised patients that a SSNB injection can 
improve symptoms very quickly and have been shown to be effective at three 
months in some patients. They also advised patients that repeat injections are 
an option after three months. All clinicians generally administered the injection 
with the patient in a seated position and the clinician standing behind. Clinicians 
report the major risks they discussed with patients were injury to the SSN and 
artery, injection of bolus into the artery, pneumothorax, depigmentation and 
infection.  
Clinicians discussed ideas for future research in relation to the method of 
delivery of drug to the SSN, such as lidocaine patches and longer lasting 
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injectable local anaesthetic. One clinician also suggested repeating a previous 
study that demonstrated that local anaesthetic agents given alone were as 
effective as local anaesthetic combined steroid in SSNB injections (Gado & 
Emery 1993). It was unclear why the clinician felt repeating this study was 
necessary and was not explored any further in the focus group. Clinicians also 
felt research furthering our understanding on the basic science of pain and 
specifically our understanding on how SSNB injections improve symptoms 
beyond the pharmacological action of the drug used was important. 
There was general consensus and agreement that informed consent is gained 
prior to administering a SSNB injection. Some clinicians capture written 
informed consent, others only verbal. The process of consent involved 
discussing the risks, and benefits of the procedure with the patient. 
 
  
Clinicians described both surface land-marked and ultrasound guided 
approaches when administering a SSNB injection. The focus group consisted of 
two clinicians who use ultrasound guided techniques in their practice and three 
clinicians who use a surface land-marked approach. Clinicians utiliing surface 
land-marked approach generally reported injecting larger volumes, up to 10ml 
P1 ‘I would talk through the procedure with a patient, I would discuss the potential risks and 
 the risks that I would normally discuss would be potential nerve damage…the potential 
 risks of needle injury to the nerve, to the blood vessels is there.  I also discuss about 
 pneumothorax, I explain that it is a very small risk, but it is in the literature and it's been 
 documented that has happened’ (line 190-198). 
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of local anaesthetic, usually 0.25% Bupivacaine. They felt a large volume was 
needed to flood the area around the SSN to ensure that the drug diffuses and 
reaches the target. All clinicians reported that patients are generally seated 
when they administer a SSNB injection. The injection is administered from 
behind targeting the SSN in the suprascapular fossa after it has entered through 
the suprascapular notch. 
 
Clinicians utilising an ultrasound guided approach felt that a large volume was 
not necessary as the ultrasound guided approach allows them to be more 
precise with needle placement close to the SSN. Clinicians utilising ultrasound 
for needle placement reported using volumes of 2-3 ml of local anaesthetic.
  
Further discussions continued around which drugs were used in SSNB 
injections. One clinician reported that based on the literature they use local 
anaesthetic alone for SSNB injections whilst the four other clinicians reported 
using a mixture of local anaesthetic and steroid.  
P4 ‘if you're injecting a larger volume and it just sort of diffuses around anyway, so you're 
going to hit the target aren’t you, you don’t have to be so precise.  So that’s one of the 
advantages of using the 10 ml.. ‘(line 490-492) 
 
P5 ‘Because I use ultrasound, I probably give between 2 – 5 ml max’ (line 430)  
P3 ‘I guess like Dr xxxx, we think sniper rifle rather than shot gun …’ (line 494) 
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In fact, clinicians who used mixed local anaesthetic and steroid, acknowledged 
that they were aware of the research supporting the use of local anaesthetic 
alone in SSNB injections, and as far as they were aware there was no evidence 
to support the use of steroid for nerve block injections. However, they reported 
that the use of steroid with local anaesthetic for nerve block injections was 
common practice although not evidence based. 
 
 
The potential risks of a SSNB injection were discussed in detail by clinicians. 
Clinicians generally felt that there were potential risks with a SSNB injection but 
side effects and any harm caused by a SSNB injection to patients were not 
regularly observed.  
P4 ‘I reviewed the literature and there was a follow up paper published that  shows that you 
 don’t need to use a depomedrome, so if you keep on giving 80 mg or 40 mg of 
 depomedrone every three months, cumulatively that could be amounting to a fair whack 
 of steroid …’ (line 420-423) 
P2 ‘I'm using the same from what xxxx was talking about 9 mil of bupivacaine and 1 ml of 
Kenalog (40mg).  Why?  Because our pain management consultants set out this, they 
trained us and we are still continuing.’ (line 445-448). 
P5 ‘I do use local anaesthetics, probably Bupivacaine and I do use steroids and we 
discussed there is no literature evidence that steroid works, but it is a practice. 
(Laughter) and I don’t use 40 I use small amount, probably 20 mg.’ (line 431-434).    
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The potential risks reported by clinicians included infection, skin 
depigmentation, injury to the suprascapular artery and suprascapular nerve by 
the needle tip, potential to inject a bolus of drug into the suprascapular artery, 
temporary weakness of the shoulder if the motor branches of the SSN were 
effected and pneumothorax if the pleural cavity was punctured if the needle tip 
slipped to deep through the suprascapular notch. Clinicians who utilised 
ultrasound reported less concerns regarding potential risks due to lower drug 
volumes used and the accuracy of needle placement that is afforded by 





P2 ‘Yes you should have advice about any infections, if they feel they have any other problems 
or if they are concerned about infections, either they have to speak to their GP or come back 
to A & E for some antibiotics.  But we've never had any problems.  I think, in 15 to 20 years 
no one has come back with any infections.’ (line 581-585). 
P4 ‘I have seen motor effect, so the patient says I can't move my arm.  It's a bit worrying, but it 
always comes back but I guess that’s a hazard of using a larger volume isn’t it, infiltrating all 
the nerves and then blocking the motor fibres as well..’(line 467-470). 
P1 ‘I think some of my anxiety when I do an injection is because we use a long needle, 
occasionally the long green needle, and what we discussed earlier about pneumothorax, 
going through the suprascapular notch and possible needle stick injury on the blood vessels, 
that’s always in the back of my mind, that probably isn’t in the back of your two minds if you 




Clinicians felt that investigating new ways of drug delivery, such as application 
of local anaesthetic patches covering the skin overlying the area of the SSN, 
and developing injectable slow acting local anaesthetics that have a longer 
lasting duration of action are areas for future research. 
 
 
Clinicians acknowledged that there was still a lack of understanding on how 
SSNB injections work beyond the pharmacological effect of the drug. They felt 
that research that furthered our understanding on the basic science of pain 





P4 ‘The other thing, I don’t know whether it's ever been tried but if you could get, you know, 
you get these lignocaine patches don’t you, like a plaster, so has anyone tried just sticking 
one of those over the same spot?’ (line 792-795) 
P1 ‘What you talked about earlier about the slow release.’ (line 800) 
P3 ‘The slow release yes.’ (line 801) 












P4 ‘I guess the actual more at the basic science level, how does it give pain relief lasting for 
three months when it's only a very short lived effect?’ (line 715-718). 
P5 ‘There is a big debate of why.  The reason being in chronic pain, for example we do an 
injection called facet median nerve block for back pain.  It is just for blocking a nerve and 
some patients get six months pain relief.  We don’t know.  One theory is that, what we call 
pain cycle, so you get a constant barrage impulses going into your spinal cord where it 
modulates and then we call plasticity and once you shut off, say a few days of input, we 
believe it takes a long time before it re-establishes but no one has proved that yet.’ (line 
719-726) 
P4 ‘Interesting yes.’ (line 727) 
M ‘Any thoughts on how you would prove it?’ (line 728) 
P5 ‘That’s very much molecular at spinal cord level isn’t it.’ (line 729) 
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Patient management (what now?) 
Within the theme of ‘patient management’ clinicians discussed topics such has 
physiotherapy and shoulder exercises, repeat injections, self-management, 
patient outcomes, clinical audit, local service delivery pathways and limited 
resources.  
Physiotherapy and shoulder exercises were viewed has an integral part of the 
overall patient management although there were different models and 
experiences of how physiotherapy was delivered in the overall package of care.  
Clinicians felt that it was appropriate to repeat SSNB injections at a minimum 
three month intervals and repeat injections could be ongoing if seen to be 
beneficial to the patient. If the relief provided by a SSNB injection was short 
lived consideration for a SSN denervation procedure is considered for some 
patients. 
Outcome measures and clinical audit data are not routinely collected by 
clinicians with the exception of one clinician who reports the regular use of the 
Disabilities of the Arm, Shoulder and Hand (DASH) and the Shoulder Pain and 
Disability Index (SPADI) outcome measures with SSNB injections. 
Clinicians identified research establishing the value and benefit of combining 
SSNB injections with physiotherapy intervention and adding a SSNB injection to 
other injection therapy procedures as important areas that needs investigating 
in future research. 
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All clinicians felt that physiotherapy and shoulder exercises had an important 
adjunct role following a SSNB injection. Clinicians reported that, from their 
experience, SSNB injections can give almost immediate relief of symptoms. 
They viewed this as an opportunity for the patient to get the shoulder moving 
immediately. Some clinicians tended to advise patients to simply move their 
shoulder, others would teach shoulder exercises, whilst others would refer 
patients to physiotherapy to be taught shoulder exercises after a SSNB 
injection. In some cases patients had already seen a physiotherapist and were 
advised to continue with self-management and follow the advice and exercises 
previous given. The general consensus from clinicians was that a SSNB 
injection provided a window of pain relief to exploit by getting the shoulder 
moving better.  
 
Most clinicians felt that SSNB injections can be effective, at, and up to, three 
months. Clinicians agreed that they would repeat a SSNB injection at a 
minimum of three months, if the previous SSNB injection provided benefit. 
 
P1 I tell them to start their exercise straight away (line 645) 
P4 Same here yes. (line 647) 
All Yes. (line 648) 
M Is there a reason for that? (line 650) 




Other clinicians would consider a denervation procedure to the SSN, if the 
SSNB injection was beneficial but had limited duration or if patients had 
problems attending for repeat injections. 
 
Measuring the effectiveness of a SSNB injection was discussed by the group. 
One clinician reported that they regularly collect outcome measures when 
administering a SSNB injection and were able to follow up their patients. Other 
clinicians reported that this was not feasible or possible within their service due 
to limited resources as they often do not follow up their patients.  
 
 
P4 I tell them I'd expect it to last for up to three months and that I would be  happy to 
 repeat it, if it proves successful, and it is something that you could continue to do on 
 a regular basis’ (line 359). 
 
P5 Again I tell them that this is sometimes just a diagnostic, just to see what we can do 
further and if it doesn’t help, then we move them onto something else, or if it works on 
the shorter time, they need to go on to denervation.  (line 282-285) 
P5 If it works three months we carry on, but if the patient tells us it's not, it's too much 
coming and going back, because the procedure is exactly the same, the only thing is, 





Clinicians reported that clinical audit was something that was undertaken in the 




An area where clinicians felt future research would be helpful included looking 
at the value of combining a SSNB injection with physiotherapy rehabilitation.  
P3 Yes so what we do is on the day of the injection we will do the SPADI and DASH and then 
we will review them one to two weeks later (line 518-519) 
M So how do you know they work? (line 552) 
P5 When they come back, after GP’s have referred back saying that it worked, can you 
please repeat it again. (line 553) 
 
P1 We had a spell where we would audit patients by telephone review, but due to the 
resources required to do that, we stopped it because we could be seeing patients for 
when we were doing reviews over the phone so that was stopped. (line 568-570) 
P5 Yes we used to do the same.  Our nurses used to call every single injection patient and 
we were told that it's not funded any more.  (line 572-573) 
 
P3 ‘Even maybe in rotator cuff tear, because if the motor component has torn, if you block 
 the suprascapular nerve, maybe you'd get better function because we get a lot of 
 people that have quite significant rotator cuff tears and you put them on an 
 anterior deltoid protocol, then they improve, but they're still painful so you end up doing 
 a subacromial injection or intraarticular injection with steroid and local anaesthetic, 
 which settles their pain down.  Maybe if you block the suprascapular nerve to knock 
 out the sensory … (line 773-780). 
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Clinicians also identified combination of injection therapy procedures as an area 
of future research, such as combining a SSNB injection with another injection 



























Chronic and persistent shoulder pain is a major problem in the UK affecting the 
quality of life of many patients (Murphy & Carr 2010). The literature indicates 
that clinicians consider a variety of interventions in the management of shoulder 
pain and the most effective and optimal approach is unknown (Bryceland et al, 
2015, Littlewood et al, 2012, Hanchard et al, 2011).  The pathogenesis and 
mechanisms underlying chronic pain are complex, most likely involving local 
tissue pathology and a complex interplay of pain pathways and sensory 
signalling that may lead to central sensitisation as result of temporary and long-
term neuroplasticity (Shanthanna et al, 2016). The changes associated with 
sensitisation may lead to modulation of afferent sensory signals, that contribute 
to the development and maintenance of chronic pain. Blocking aberrant afferent 
inputs, even temporarily, in some patients with chronic pain, may provide 
prolonged pain relief (Arnér et al, 1990). SSNB injections may be an effective 
treatment option for some patients with chronic shoulder pain (Chang et al, 
2016, Chan and Peng 2011) however little is known regarding the use and 
clinical application of SSNB injections in clinical practice. From the literature 
search no information could be found regarding the use and clinical application 
of SSNB injections in clinical practice in the UK. In fact, surveys investigating 
the management of shoulder pain in clinical practice in the UK, indicated that 
SSNB injections were not widely considered, with local steroid injections into 
the subacromial space and glenohumeral joint being the main injections of 
choice for different shoulder conditions (Bryceland et al, 2015, Littlewood et al, 
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2012, Hanchard et al, 2011,). This also appears to correlate with clinical 
practice in Australia, where a survey of GP’s and Rheumatologists undertaken 
between 2003 and 2009, also indicated that clinicians mainly considered local 
steroid injections into the subacromial space or glenohumeral joint for different 
shoulder conditions, although SSNB injections were considered by some 
clinicians in this survey, mainly for patients with frozen shoulder (Buchbinder et 
al, 2013).  
The main objective of this study was to develop an in-depth understanding of 
the use and application of SSNB injections, from the perspective of clinicians 
who use SSNB injections in their clinical practice. A secondary aim was to 
identify if and where future research in this area was needed. This discussion 
aims to bring together the findings from this focus group and consider them 
alongside the current literature, theory and evidence base, in order, to build a 
knowledge base around this topic and identify if and where future research is 
needed.  
 Patient selection  
One of the main objectives of this study was to develop an understanding of 
how clinicians decide which patients were considered appropriate for SSNB 
injections within their practice. Identifying and predicting which patients respond 
to specific treatments has clear benefits for patients and healthcare resources.  
Clinicians were recruited purposively to this focus group study based upon their 
experience, profession and the locations and sectors they practiced. The 
clinicians involved were based within community, intermediate and secondary 
care services and from Pain Management, Rheumatology and Physiotherapy 
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professional groups. It was anticipated that clinicians from different professions 
and working in different sectors may give different perspectives.  
The factors influencing a decision to consider a SSNB injection, in a patient 
referred to a secondary care pain or rheumatology clinic, could be different to 
the factors influencing a decision made by a clinician working in the community 
or an intermediate care service. Patients referred to secondary care may have 
received multiple interventions before referral, therefore limiting the remaining 
viable options available for treatment. Clinicians working in community and 
intermediate care, that see and treat patients earlier in their journey, may have 
the opportunity to consider a SSNB injection earlier for a patient compared to 
those clinicians working in secondary care.  
Interestingly, all the clinicians in this study reported that SSNB injections were 
generally reserved for patients that had failed to improve with other treatments 
first, including local steroid injections, physiotherapy and surgery, rather than 
specifically identifying which patients they felt were more appropriate for a 
SSNB injection. SSNB injections appeared to be viewed as a treatment of last 
resort by clinicians and consequently, the majority of patients that they treated 
with SSNB injections, had long standing shoulder pain, often for more than six 
months and had previously received multiple interventions with minimal or no 
success. It was unclear why clinicians adopted this approach.  
It may be that clinicians have uncertainty regarding the effectiveness of SSNB 
injections compared to the effectiveness of local steroid injections. Local steroid 
injections are widely used in clinical practice and may be perceived and 
accepted, within a battery of first line treatment options in the management of 
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shoulder pain (Bryceland et al, 2015, Littlewood et al, 2012, Hanchard et al, 
2011). This view appears to be supported in the literature. A recent NICE 
accredited commissioning guide on the management of subacromial shoulder 
pain, suggested that SSNB injections may be considered in secondary care, as 
part of a complex package of care for patients that are not considered fit or 
choose not to have surgery. Conversely, the commissioning guide suggested 
local steroid injections, could be considered as a treatment option delivered 
alongside physiotherapy in primary and intermediate care (Kulkarni et al, 2015, 
Kulkarni & Rees 2015).  
Clinicians in the focus group felt that future research investigating the 
effectiveness of SSNB injections, compared to local steroid injections, given 
much earlier to patients, may be helpful in guiding and informing clinical practice 
in this area. Three RCT show favourable outcomes of SSNB injections 
compared to local steroid injections for patients with chronic shoulder pain 
(Emery et al, 1989), frozen shoulder (Jones and Chattopadhyay 1999) and non-
specific shoulder pain (Taskaynatan et al, 2005). However, all these studies had 
small sample sizes. Therefore, more robust research, that is adequately 
powered, is required to investigate the effectiveness of SSNB injections 
compared to local steroid injections. 
Although clinicians indicated that SSNB injections were generally considered 
after other treatments had failed, one clinician provided some further insight into 
their clinical reasoning and the challenges of deciding the most appropriate 
treatments for patients. They reported that, if they considered the shoulder 
condition to have an inflammatory component they would consider a local 
steroid injection. The assessment approach or criteria used by the clinician, to 
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inform their decision and determine the main pain driver i.e. ‘inflammatory’ in 
this case, was not discussed. Clearly, establishing the ‘mechanisms’ and main 
‘pain drivers’ underpinning a patient’s condition, in clinical practice, could be 
advantageous and may help target treatments more effectively. If an 
inflammatory component is seen has the main pain driver, then a local steroid 
injection may be the most appropriate injection. If an inflammatory component is 
not seen as the main pain driver, then arguably, a local steroid injection may not 
be the treatment of choice and targeting treatments at peripheral tissue 
pathology or inflammation, using a local steroid injection may be futile. 
Chronic pain is complex. Some patients with chronic shoulder pain may have 
ongoing local tissue pathology and inflammation that may be driving their 
symptoms. Other patient’s symptoms however may be more associated with 
central sensitisation. Some patients may have elements of both. However, 
being able to determine the mechanisms involved in chronic pain, in order, to 
target those mechanisms with more specific treatments, remains a challenge, 
due to the lack of validated clinical diagnostic tools available in clinical practice 
(O'Leary et al, 2017, Woolf 2011, Smart et al, 2011).  
The concept of central sensitisation was briefly discussed by participants in this 
focus group in relation to pain neurophysiology and the theory of how nerve 
block injections may provide prolonged pain relief; by interrupting the constant 
barrage of afferent input and modulation of central processing. Although not 
discussed in detail within this focus group, it may be advantageous to explore 
further the concepts surrounding the assessment and treatment of chronic 
shoulder pain, in patients with central sensitisation, in future exploratory 
research. No clinical trials could be found investigating the effects of SSNB 
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injections in patients with recognised central sensitisation. Clinical trials 
involving sub-grouping patients have mainly been based upon categories such 
has frozen shoulder and subacromial pain. Evidence suggests SSNB injections 
are effective in reducing pain and improving function in patients with frozen 
shoulder (Klc et al, 2015; Dahan et al, 2000; Jones & Chattopadhyay 1999) and 
in patients with subacromial pain (Bayram et al, 2014; Di Lorenzo et al, 2006; 
Vecchio et al, 1993). A SSNB injection could block the sensory fibres of up to 
70-80% of the shoulder and peri-shoulder structures and therefore, in theory, 
may be an effective treatment option for relieving symptoms for a number, of 
shoulder conditions. None of the clinicians in the focus group expressed any 
views on whether they limited SSNB injections to patients with specific shoulder 
conditions or from their experience whether SSNB injections were any more 
effective for any specific shoulder conditions. They did however feel that future 
research identifying if specific shoulder conditions were more amenable to a 
SSNB injection as potentially important future research.  
One clinician in the focus group expressed concerns regarding repeating local 
steroid injections due to the potential side effects that glucocorticoid steroids 
may have on the rotator cuff tissue. They reported that a SSNB injection was 
sometimes considered for patients, who had already received multiple local 
steroid injections in the same shoulder. Experimental studies suggest 
glucocorticosteroids may have a negative effect on tendon tissue (Dean et al, 
2014a, Dean et al, 2014b). This emerging evidence therefore questions whether 
repeated local steroid injections at the shoulder are a sensible approach for 
some patients. Arguably injections other than local steroid injections may be a 
more reasonable approach for a number of patients, including those patients 
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that may ultimately be considered for surgery, such as a rotator cuff repair, are 
on a waiting list for surgery but pain is not well controlled, as well as those 
patients where surgery is not being considered but pain is not well managed 
and are struggling with rehabilitation.  Currently, there is little evidence to guide 
and inform clinical decision making regarding which patients are more 
appropriate for a SSNB injection rather than a local steroid injection. Clinicians 
in this focus group feel SSNB injections may have a wider role to play in the 
non-surgical management of shoulder pain then waiting to treat chronic 
persistent shoulder pain, that is unresponsive to other treatments. Clinicians 
feel further research is needed to investigate the effectiveness of SSNB 
injections compared to local steroid injections in treating patients with different 
shoulder conditions. Further consideration may also need to be given regarding 
the underlying mechanisms involved in patients symptoms and whether sub 
grouping patients based on the mechanisms involved such has inflammatory or 
sensitisation for example is more appropriate than sub grouping patients based 
on a clinical diagnosis. Further exploratory and preliminary research may also 
be needed to develop further understanding on how to identify, recognise and 
categorise patients with shoulder pain in order to target treatments more 
specifically. 
The intervention 
A further objective of this study was to identify the techniques, approaches, 
drugs and dosages used by clinicians in this focus group when administering a 
SSNB injection, as well as exploring and establishing clinicians’ reasons and 
choices. The purpose for this objective was to identify and explore any 
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differences and commonalities in practice, but also to explore any uncertainties 
that clinicians may have that may go on to inform future research in this area.  
A variety of local anaesthetic agents, used alone or in combination with steroids 
have been used for SSNB injections in published clinical studies (Table 1, page 
23). However, no specific drug or combination of drugs have been proven to be 
any more effective. The rationale for using local anaesthetic agents for nerve 
block injections, is to block aberrant afferent signals from the symptomatic 
region, with the aim of reducing central sensitisation associated with chronic or 
persistent pain (Basbaun 2009). However, the rationale for using steroids within 
nerve block injections (or intra-articular / periarticular injections) in the 
management of chronic pain is unclear (Shanthanna et al, 2016).   
Even within this focus group of only five clinicians, significant variation existed 
regarding the injection approach and drugs used when administering a SSNB 
injection. Three clinicians used the indirect, surface land-marked approach, 
described in Chan and Peng (2011) and two clinicians utilise an ultrasound 
guided approach. Four clinicians used a mixture of local anaesthetic and 
steroid, with one clinician choosing to inject local anaesthetic alone. The two 
clinicians that utilised ultrasound guidance used less drug volumes and steroid 
concentration (2-3 ml of local anaesthetic and 20 mg steroid) compared to the 
three clinicians utilising a surface land-marked approach (10 ml local 
anaesthetic +/- 40 mg steroid). The rationale for using ultrasound guidance 
surrounded concepts of safety and efficacy. Ultrasound guidance offers more 
accurate needle placement close to the SSN therefore reducing the risk of 
needle stick injury to the SSN and blood vessels, avoidance of pneumothorax 
as well as reducing the volume of drug needed to gain the desired blockade. 
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Clinicians using land marked approaches injected larger volumes to flood the 
area around the SSN with some clinicians expressing some concerns about 
potential side effects and safety when using a larger volume of local anaesthetic 
that may cause transient weakness of the shoulder muscles. The literature 
suggests that ultrasound guided approaches have become a more accepted 
approach for SSNB injections (Chan and Peng 2011, Cheng et al, 2016). 
Ultrasound guided approaches were also reported to be more effective then 
land-marked approaches in a meta-analysis by Cheng et al, (2016). However, 
these claims were based upon studies investigating SSN denervation and 
continuous indwelling catheters not SSNB injections. Although different guided 
and landmarked approaches are described in the literature no specific approach 
has been shown to be more effective. The indirect land-marked approach used 
by three clinicians in this study was the land-marked approach used in 9 out of 
16 studies involving land-marked approaches that were discussed within the 
introduction of this thesis and presented in table 1 (page 23).  The indirect land-
marked approach is reported to be safe and acceptable to patients based upon 
an observation study of over 1000 SSNB injections performed in Australia 
between 2003 and 2009 (Shanahan et al, 2012). From the 1005 SSNB 
injections performed no serious side effects were reported, with only three 
episodes of transient dizziness, two episodes of transient arm weakness and 
one episode of facial flushing. Although none of the participants in this focus 
group had experienced any serious side effects in their patients following SSNB 
injections, they recognised that ultrasound guidance provides clinicians with a 
level of confidence that land-marked approaches did not.  
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One participant in this focus group reported using local anaesthetic alone when 
administering SSNB injections, with all other clinicians using a combination of 
local anaesthetic and steroid. The clinician who administer local anaesthetic 
alone felt that the addition of steroid was not necessarily for a SSNB to be 
effective. In fact, various studies indicate that SSNB injections using local 
anaesthetic alone may provide effective pain relief beyond the pharmacological 
action of the drug (Dorn et al, 2015, Lotero et al, 2013, Kang et al, 2012, Di 
Lorenzo et al, 2006, Taskaynatan et al, 2005, Karatas and Meray 2002, Dahan 
et al, 2000, Gado and Emery 1989, Rowlingson and Arasi 1986). However, only 
one study investigated whether the addition of steroid provides any further 
benefit to local anaesthetic alone (Gado and Emery 1993). In this study twenty-
nine patients with RA and chronic bilateral shoulder pain were recruited. The 
patients worst shoulder was randomised to receive 2 ml of 0.5% bupivacaine or 
2 ml 0.5% bupivacaine combined with 40 mg of prednisolone. The contralateral 
shoulder to the treatment shoulder was however also injected with 40 mg of 
prednisolone. Both groups improved with no difference between groups. The 
authors therefore claimed that the addition of steroid within a SSNB injection 
provided no additional benefit over SSNB injection with local anaesthetic alone. 
However low participant numbers and with the treatment group receiving a dose 
of steroid in the contralateral shoulder, that may have a systemic effect, 
questions the methodological quality and findings in this study. Using local 
anaesthetic alone in SSNB injections may have clinical benefits where the 
injection could to be administered and repeated without any of the risks 
associated with repeat steroid administration. This may have important 
implications for rehabilitation and be an appropriate option for patients where 
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administration of steroid is not recommended i.e. uncontrolled diabetes.  Future 
research investigating whether the addition of steroid to local anaesthetic 
provides any additional benefit to local anaesthetic alone for SSNB injections 
may be an important future study that could guide and inform clinical practice in 
this area. In addition, further consideration may need to be given regarding the 
use of ultrasound guidance if considering the use of local anaesthetic alone. 
There may be different outcomes for SSNB injections administered with or 
without steroid when using ultrasound guidance, due to the potential systemic 
effects of steroid. Within this theme clinicians also briefly discussed future 
potential developments in pain management, such has the use of slow acting, 
long lasting local anaesthetics within injections, as well as novel ways of drug 
delivery such has applying local anaesthetic patches over a target area.  
 Patient Management 
Arguably the management of patients with chronic shoulder pain can be 
complex often involving multiple modalities and interventions. A further objective 
of this study was to identify which aspects of clinical care, including addition 
interventions, are associated with the management of patients who receive 
SSNB injections. In addition, participants were asked to explore how future 
research could consider overall management and adjunct interventions for 
patients with chronic shoulder pain receiving SSNB injections.  
Participants discussed topics such has combined interventions, physiotherapy, 
shoulder exercises, self-management, patient outcomes, clinical audit, local 
service delivery pathways and limited resources. Essentially participants 
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discussed how these aspects of clinical care fit within the overall concept of 
‘Patient Management’ when a patient is considered for a SSNB injection.   
All the clinicians in this focus group felt that physiotherapy and especially 
shoulder exercises play an important part in the overall management of patients 
that undergo SSNB injections. They felt that the objective of a SSNB injection 
was to reduce pain and following a SSNB injection shoulder exercises were 
essential in restoring or improving function in patients with chronic shoulder 
pain. One clinician shared their views on how a SSNB injection may facilitate 
rehabilitation in patients with rotator cuff tears.  Much debate and uncertainty 
exists regarding the safe use of local steroid injections to facilitate rehabilitation 
in the management tendonopathy due to the potentially negative effects that 
glucocorticosteroid may have on tendon tissue (Coombes et al, 2010). One 
study investigating the combined effects of physiotherapy and local steroid 
injection, for subarcomial shoulder pain, showed that patients who received 
both subacromial injection and physiotherapy had a quicker recovery than those 
that received physiotherapy alone (Crawshaw et al, 2010). Although long term 
outcomes at three months were similar earlier recovery may have important 
implications for some patients. A study investigating SSNB injections combined 
with physiotherapy compared to physiotherapy alone, in patients with frozen 
shoulder, showed that the SSNB group had greater improvements in outcomes 
than the physiotherapy alone group at seven weeks (Klç et al, 2015). However, 
a limitation of this study was the small sample size of only 40 patients and the 
short follow up to only seven weeks.  
One of the benefits of a SSNB injection reported by clinicians in the focus group 
was that it can produce almost immediate relief of symptoms in some patients. 
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They felt that this was very rewarding for clinicians and highly valued by 
patients particularly when all other treatments had failed. The potential 
implications regarding quick resolution of pain for physiotherapy management, 
after a SSNB injection, could be advantageous and quite significant. Patients 
may be able to start shoulder exercises immediately after SSNB injections, this 
may not be the case following a local steroid injection considering the potential 
risks associated with altered tendon homeostasis (Dean et al, 2014a, Dean et 
al, 2014b). In theory, other physiotherapy treatments including manual therapy 
may also be facilitated and supplemented by a SSNB injection and initiated 
after a successful SSNB injection. In fact, this appears to be the rationale for the 
procedure initially reported by Wertheim and Rovenstine (1941 p.541) i.e. the 
procedure may be ‘useful as an adjunct in the treatment of chronic shoulder 
pain’ and to enable other treatments such has ‘traction, manipulation and 
massage to be applied to a painful shoulder’.  In fact, two recent review articles 
suggest that future studies should aim to identify the optimal timing of SSNB 
injections in combination and integration with physiotherapy, in order to improve 
long term benefits of SSNB injection (Cheng et al, 2016, Chan and Pend 2011).   
Some clinicians in the focus group also report that some of their patients felt 
more confident with self-management and were able to continue with home 
exercises independently after a SSNB injection. Clinicians generally felt SSNB 
injections were effective in their patients up to three months and would be 
prepared to repeat a SSNB injection at three month intervals if required.  
Although these observations were anecdotal and were generally based on 
patients that were re-referred and considered for a repeat injection, the 
literature indicates that improvements in pain and function following SSNB 
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injections in patients with non-specific chronic shoulder pain, frozen shoulder 
and subacromial pain are maintained up to three months (El-Badawy et al, 
2104; Bayram et al, 2014; Emery et al, 1989). No study could be found that 
measured outcomes beyond three months (Table 1, page 22).   
Clinicians also identified that SSNB injection used in combination with other 
treatments including hydro-distension for frozen shoulder was worth exploring 
within future research. SSNB injection may make a procedure such a hydro-
distension more comfortable for patients but also improve effectiveness of the 
procedure. Outcome measures were not routinely collected by clinicians in this 
focus group due to lack of resources in clinical practice that allow them to 
regularly follow up patients. One clinician reported collecting short term 
outcomes, using SPADI and Quick DASH, at two to three weeks post SSNB 
injection. Furthermore, one clinician in the focus group felt that return to work 
should be considered an outcome measure in future research and clinical 
practice. The main finding within this theme centred around the importance of 
combining a SSNB injection with physiotherapy and shoulder exercises. 
Study strengths 
Previous research investigating clinical practice surrounding the management of 
shoulder pain has generally used survey methods to provide an overview of 
clinical practice. No exploratory or mixed method research, specifically 
regarding the clinical application of SSNB injections, was identified by the 
author in which to build upon. Focus groups are particularly suited to an 
exploratory approach and this method provided clinicians in this study with an 
interactive platform to discuss and share their views and experiences. This 
study included a purposive sample of participants from different clinical sectors 
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and from different professional backgrounds who provided different 
perspectives and experiences around the use of SSNB injections. Several 
strategies were adopted to improve the trustworthiness of the findings in this 
study including collaboration with co-researchers, use of an experienced 
facilitator, providing thick descriptions and member checking.  
Limitations 
Only one focus group was undertaken for this exploratory study. Undertaking 
further focus groups across a wider geographical region involving orthopaedic 
consultants, radiologists and general practitioners would have improved the 
credibility of the findings. Only five participants were involved in the focus group 
including the main researcher and their involvement in the focus group had the 
potential to introduce bias.  Further data collection and triangulation with other 
data collection methods, such has individual interviews or even a survey would 
also have strengthened the findings. Pilot testing the topic guide and having the 
research methods peer-reviewed by an expert independent researcher before 
the start of the study would have also improved the dependability of the 
findings.  
Next stage 
Participants in this study identified future clinical research that could ultimately 
guide and inform clinical practice in the area of SSNB injections in the non-
surgical management of shoulder pain. However, further exploratory research 
undertaken with clinicians using SSNB injections from across a wider 
geographical region would be useful first.  In addition it would also be useful to 
gain the views, experiences and perspectives of patients living with chronic 
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shoulder pain.  The findings from this initial focus group could be used to 
construct questions within a survey, that would reach a wider sample within the 
UK and further afield, or be used to construct further questions in a topic guide 





This study aimed to investigate and explore the views and experiences of 
clinicians that use SSNB injections in the non-surgical management of shoulder 
pain. Clinicians in this focus group currently reserve SSNB injections for 
patients with long standing shoulder pain that has been refractory to other 
treatments including local steroid injections, physiotherapy and surgery. 
Clinicians report that most patients have had symptoms for at least six months 
before considering a SSNB injection and they were happy to repeat SSNB 
injections at three month intervals if necessary. No specific shoulder conditions 
are excluded from having a SSNB injection and SSNB injections were not 
reported to be any more effective, in any specific shoulder condition. Clinicians 
used both land-marked and ultrasound guidance and used local anaesthetic 
alone or in combination with glucorticosteroid.  
All clinicians felt that physiotherapy and shoulder exercises were an important 
part in the overall management of patients with chronic shoulder pain, following 
a SSNB injection. The optimal timing of these interventions may be important 
component for effective management and future research exploring this concept 
would be useful.  Clinicians also identified that future research investigating the 
effectiveness of SSNB injections compared to local steroid injections for 
different shoulder conditions as an important area. Consideration however may 
need to be given regarding sub grouping patients based upon condition and 
whether patients have elements of central sensitisation. They also identified 
future research to investigate if SSNB injections given earlier to patients are 
effective, if SSNB injection administered with local anaesthetic alone is as 
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effective as SSNB injections administered with glucocorticoid combined with 
local anaesthetic and if SSNB injection adds any further benefit to other 
treatments like hydro-distension for frozen shoulder? Future research in this 
area has the potential to guide clinical practice and improve the quality of life of 
patients living with chronic shoulder pain, however further exploratory research 
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Appendix 1: Literature search strategy 
Data sources and search strategy  
A literature search was conducted in March 2016. Articles listed in electronic 
databases AMED, CiNAHL, MEDLINE, Embase, were retrieved through accessing 
NHS Evidence, Journals and Databases. The Cochrane Library, Pedro and 
Scopus were also accessed online. Furthermore, both Academic Search Complete 
and SportDiscus were also accessed through Coventry University EBSCOhost. A 
web based search of Google scholar from 2012 onwards was also conducted to 
identify possible further studies. Reference lists of retrieved articles and reviews 
were also screened for studies that were not identified by the electronic search of 
the databases. The subject heading and key words; suprascapular nerve block(s) 
were used for the search terms within all text of articles.  
Inclusion criteria 
Both observational studies and randomised controlled trials (RCTs) of English 
language only were included in this review.  Only studies that investigated the 
effectiveness of SSNB injection in the conservative management of 
musculoskeletal shoulder pain were included. Studies could investigate guided 
techniques such has CT, fluoroscopy, EMG and ultrasound or unguided 
approaches such has landmarked approaches. Study participants were required to 
be adults (over the age of 18 years) with a diagnosis of musculoskeletal shoulder 
pain. The diagnosis could be specific or non specific shoulder pain. Studies were 
required to report on at least one or more outcome measures of shoulder 
impairment, disability, pain or function.  
Exclusion criteria 
Studies not in English. Single case studies were not included. Studies looking at 
the effectiveness of SSNB injections in post surgery patients, in cancer related 
pain, post stroke shoulder pain, pain of cervical origin and neurological shoulder 
pain i.e. suprascapular neuropathy were not included. Studies looking at SSN 
denervation, the use of indwelling catheter for continuous nerve blockade and 
pulsed radiofrequency procedures were also not included.  
Results 
The initial electronic search of databases resulted in retrieval of 686 articles. 
Removal of duplicates from within each database reduced the number of articles 
by 3 to 683. These 683 articles along with the additional 4 other articles, retrieved 
through a web based search, were screened by title and abstract (n687).  Of these 
687, 663 articles were then excluded due to inappropriate subject, not meeting the 
inclusion criteria and being duplications not previously removed by the function 
within the database search platforms. The remaining 24 articles were then 
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Suprascapular nerve block* (n=686) 
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Study Title Subjects Design Outcome Measures Findings 
1.Mitra, P. K. and 
Bhattacharya, D. (2016) 
'Comparison of Clinical Effects 
of Ultrasound Guided 
Suprascapular Nerve Block 
and Oral Pregabalin Versus 
Suprascapular Nerve Block 
Alone for Pain Relief in Frozen 
Shoulder'. Indian Journal of 
Pain 30 (1), 49  
Frozen 
shoulder 8-9 








US guided SSNB & oral 
pregabalin vs US guided 
SSNB alone.  
3 SSNB injection 1 weeks 
apart. 
40mg methylprednisolone 
& 9ml 0.25% Bupivacaine) 
 75mg Pregabalin @ night. 




Baseline, Weeks 4, 6 
&12 
Both gps ss 
improvements in pain 
and ROM @ 4, 6 & 12 
weeks. 
 
ss additional benefit 
with pregabalin both 
OM @ week 4,6 & 12 
2.Chansoria, M., Das, G., 
Mathankar, N., Chandar, D., 
Vyas, N., and Upadhyay, S. 
(2015) 'A Preliminary Study of 
a Novel Technique of 
Suprascapular Nerve Block in 
Treating Chronic Shoulder 
Pain'. Indian Journal of Pain 








M30 F 10 
Observational. 
 






Non validated pain 
score 1-4 
Week 1& 4 
ss improvements @ 
weeks 1 and 4 all 
outcome measures 
3.Dorn, C., Rumpold-
Seitlinger, G., Farzi, S., Auer, 
J., and Bornemann-Cimenti, 
H. (2015) 'The Effect of the 
Modified Lateral 
Suprascapular Block on 
Shoulder Function in Patients 
with Chronic Shoulder Pain'. 
Anesthesiology and Pain 





Cal tend 6 
Rot cuff 6 
Arthrosis 2 
duration of 
Sx?   
n20 
Age 52 
M 9 F 11 
Observational. 
 
One injection and observe. 
 
5ml 0.5% ropivacaine. 
 
Indirect approach- Feigl. 
 
CMS 
Pain NRS (VAS) @ rest 
and on mvt. 
 
1hr and 24 hrs post 
injection. 
All outcomes sig 
improvement to 
baseline at both 1hr 
and 24 hr.  
4.Klc, Z., Filiz, M. B., Cakr, T., 
and Toraman, N. F. (2015) 
'Addition of Suprascapular 
Nerve Block to a Physical 
Therapy Program Produces an 
Extra Benefit to Adhesive 
Capsulitis: A Randomized 
Controlled Trial'. American 
Journal of Physical Medicine 
& Rehabilitation / Association 
of Academic Physiatrists 94 




@ least 1 mth 
Duration of Sx 
unknown n41 




Age 55 & 61 
M 31 F 10 
RCT. 
SSNB (followed by 
physiotherapy) Vs 
physiotherapy alone.  
Physiotherapy included 15 
sessions. 5 days a week for 
3 weeks. 
Hot packs, tens, US, 
manual therapy, Ex’s, HEP. 






Baseline, 3 & 7 weeks.  
Both gp’s showed ss 
improvements in BPI-
SF and CSS at 3 & 7 
weeks compared to 
baseline.SSNB plus 
physiotherapy gp has 
ss greater 
improvement than 
physiotherapy alone in 
the CSS, and in 4 
domains of the BPI-SF 
at week 3 and 3 
domains of BPI-SF at 7 
weeks.  
No difference in CSS 




5.Bayram, K., Bal, S., Safa 
Satoglu, I., Kocyigit, H., 
Gürgan, A., Akcay, S., and 
Kazimoglu, C. (2014) 'Does 
Suprascapular Nerve Block 
Improve Shoulder Disability in 
Impingement Syndrome? A 
Randomized Placebo- 
Controlled Study'. Journal of 




Onset 3/12 or 
more. 










9ml 2% prilocaine & 40mg 





@ Baseline, 30 min, 
2/52 & 3/12. 
SSNB gp sig. 
improvement in pain 
and function @ 2/52 & 
3/12. 
6.El-Badawy, M. A. and 
Fathalla, M. M. (2014) 
'Suprascapular Nerve Block 
Followed by Codman's 
Manipulation and Exercise in 
the Rehabilitation of 
Idiopathic Frozen Shoulder'. 
Egyptian Rheumatology and 












SSNB injection followed by 
Codman exercises 15 
minutes later. 







VAS at rest and mvt 
1/52, 6/52 & 12/52 
sig improvement in 
ROM weeks 1, 6 & 12. 
sig decrease in pain at 
rest weeks 1, 6 & 12. 
sig decrease in pain on 
mvt weeks 6 & 12. 
sig decrease in SDQ 
weeks 1, 6 & 12. 
7.Salgia, A., Agarwal, T., Puri, 
S. R., Sanghi, S., and 
Mohapatra, A. (2014) 'Role of 
Suprascapular Nerve Block in 
Chronic Shoulder Pain: A 
Comparative Study of 60 
Cases'. Medical Journal of 









3 mths or 
more 
RCT.  
SSNB Vs saline.  




n30 each gp.  
Age 50-51 




Baseline, day 2, 7, 21 & 
3 mths.  
ss improvement in 
both OM SSNB group 
to baseline all days. 
 
ss difference between 
gps all days.  
 
No improvement with 
saline.  
 
8.Lotero, M. A. A., Díaz, R. C. 
R., Escobar, D. C., Aguilar, M. 
A. M., and Ramírez, S. M. M. 
(2013) 'Efficacy and Safety of 
Ultrasound-Guided 
Suprascapular Nerve Block in 
Patients with Chronic 
Shoulder Pain'. Revista 
Colombiana De 













M 10 F 36 
Observational. 
8ml 0.5% bupivacaine 
US guided  
Pain (VAS) 
 
Baseline, 2 days, 1 
month 
Ss improvement in pain 
@ 2 days and 1 month 
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9.Ozkan, K., Ozcekic, A. N., 
Sarar, S., Cift, H., Ozkan, F. U., 
and Unay, K. (2012) 
'Suprascapular Nerve Block 
for the Treatment of Frozen 
Shoulder'. Saudi Journal of 


















& 5ml 1& lidocaine. 
 






Baseline, week 1, 4 & 
12. 
SS improvements all 




10.Kang, S. S., Jung, J. W., 
Song, C. K., Yoon, Y. J., and 
Shin, K. M. (2012) 'A New 
Anterior Approach for 
Fluoroscopy-Guided 
Suprascapular Nerve Block-a 
Preliminary Report'. The 















2ml 1% mepivacaine  
 
Fluoroscopy guided 
Pain (NRS) VAS 
 
5 minutes after block. 
Ss improved pain after 
block. 
11.Shanahan EM (1), 
Shanahan KR, Hill CL, Ahern 
MJ, Smith MD. (2012) 'Safety 
and Acceptability of 
Suprascapular Nerve Block in 
Rheumatology Patients. '. Clin 



























adverse effects.  
 
6 adverse effects (3 
transient dizziness, 2 
transient arm 













12.Gorthi, V., Moon, Y. L., and 
Kang, J. H. (2010) 'The 
Effectiveness of 
Non-specific 
shoulder pain.  
RCT.  
US guided SSNB Vs 





Suprascapular Nerve Block for 
Perishoulder Pain'. 
Orthopedics 33 (4)  










Approach for unguided 
unclear.US gp SS notch.  
 
8ml 12.5% dextrose sol. & 




after injection and 
1/12 
 
day and 1/12. 
  
SS difference between 




13.Di Lorenzo, L., Pappagallo, 
M., Gimigliano, R., Palmieri, 
E., Saviano, E., Bello, A., 
Forte, A., DeBlasio, E., and 
Trombetti, C. (2006) 'Pain 
Relief in Early Rehabilitation 
of Rotator Cuff Tendinitis: 
Any Role for Indirect 
Suprascapular Nerve Block?'. 







4.5 weeks n40 
gp 1 n20 




Randomised - crossover.  
 
gp1- Two SSNB injections 1 
week apart, followed by 
physiotherapy.  
gp2- physiotherapy 
followed by two SSNB 
injections one week apart. 
 
10ml 2% lidocaine diluted 










Pain daily.  
Disability day 28. 
Gp1 had sig 
improvement in pain 
during physiotherapy 
session than gp2.  
 
gp1 reported better 
outcomes at 28 days 
but not sig. 
14.Taskaynatan, M. A., 
Yilmaz, B., Ozgul, A., 
Yazicioglu, K., and Kalyon, T. 
A. (2005) 'Suprascapular 
Nerve Block Versus Steroid 
Injection for Non-Specific 
Shoulder Pain'. The Tohoku 
Journal of Experimental 




range  7-16 
mths 
n60 






SSNB Vs Subacromial 
injection. 
  
SSNB -Direct approach 
10ml 1% lidocaine.  
 
SAI – 40mg depomedrol & 
6ml 1% lidocaine anterior 







Within 5-7 days of 
injection and 1 month.  
 
 
Both gps SS 
improvements from 
baseline all outcome 
measures. 
  
No ss difference 
between gp’s. 
15.Schneider-Kolsky, M., Pike, 
J., and Connell, D. (2004) 'CT-
Guided Suprascapular Nerve 
Blocks: A Pilot Study'. Skeletal 









CT guided SSNB 
 
3ml Bupivacaine & 1ml 




after, 3 days, 3 weeks, 
6 weeks. 
ss improvements in 
both pain day 3, 3 
weeks and 6 weeks and 
disability domain of 




OA 2  
Unknown 9 
Duration 







16.Dahan, T. H., Fortin, L., 
Pelletier, M., Petit, M., 
Vadeboncoeur, R., and Suissa, 
S. (2000) 'Double Blind 
Randomized Clinical Trial 
Examining the Efficacy of 
Bupivacaine Suprascapular 
Nerve Blocks in Frozen 
Shoulder'. The Journal of 




















3 injections @ 7 day 
intervals.  





Both groups given 
shoulder exercises to 






@ Baseline & 1/12. 
SSNB sig improvement 
in pain @ 1/12. 
17. Emery, P., Bowman, S., 
Wedderburn, L., and 
Grahame, R. (1989) 
'Suprascapular Nerve Block 
for Chronic Shoulder Pain in 
Rheumatoid Arthritis'. BMJ 

















1 shoulder receives sham 
GHJ injection the other 
active SSNB  
 or  
1 shoulder receives sham 




SSNB (2ml - 40mg 
methylprednisolone & 
0.5% bupivacaine and 
adrenaline). 
 
Pain (VAS). Stiffness 
(VAS). 
ROM. 
Pain index (modified 
Richie index). 
 
Baseline, week 1, 4 & 
12. 
SSNB gp sig 
improvement in pain 
week 1 & 4,  
with GHJ gp only week 
1. 
  
Both SSNB and GHJ sig 
improvement in 
stiffness week 1 & 4. 
 
(12 patients felt SSNB 






GHJ (2ml - 40mg 
methylprednisolone & 1% 
lidocaine). 
18. Gado, K. and Emery, P. 
(1993) 'Modified 
Suprascapular Nerve Block 
with Bupivacaine Alone 
Effectively Controls Chronic 
Shoulder Pain in Patients with 
Rheumatoid Arthritis'. Annals 









unknown n29   
58 shoulders 
SSNB n29  






(SSNB - LA with or without 
Steroid). 
2ml 0.5% Bupivacaine Vs 
2ml 0.5% Bupivacaine with 
40mg Prednisolone. 
Worse shoulder 
randomised to treatment. 






Baseline, weeks 1,4 & 
12 
Sig improvements in 
pain & stiffness from 
baseline both groups 
@ weeks 1, 4 & 12.  
Variability in ROM but 
overall improvements 
both gps.  
No difference between 
gps. 
The addition of 
Prednisolone provide 
no further benefit. 
19. Jones, D. S. and 
Chattopadhyay, C. (1999) 
'Suprascapular Nerve Block 
for the Treatment of Frozen 
Shoulder in Primary Care: A 
Randomized Trial'. The British 
Journal of General Practice : 
The Journal of the Royal 
College of General 












Single SSNB Vs GHJ 
injections.  
 
GHJ - 20mg triamcinolone 
& 4.5 ml 2% lidocaine. 
Avg. no of GHJ injections 
2.2. 
 
SSNB - 20mg 
triamcinolone & 9.5ml 
0.5% bupivacaine.  
Indirect approach.  
Shoulder ex’s at home.  




Baseline, 1, 3, 7 & 12 
weeks.  
More complete 
resolution of Sx in 
SSNB gp.  
 
Stats ? 
20. Shanahan, E. M., Smith, 
M. D., Wetherall, M., Lott, C. 
W., Slavotinek, J., FitzGerald, 
O., and Ahern, M. J. (2004) 
'Suprascapular Nerve Block in 
Chronic Shoulder Pain: Are 
the Radiologists Better?'. 
Annals of the Rheumatic 








Duration of Sx 





CT guided vs non guided.  
 
CT – 3ml 0.5% bupivacaine 
& 40 mg 
methylprednisolone. 
Non- guided 10ml 0.5% 
bupivacaine & 40mg 
SPADI 
Pain at night, pain at 
rest, pain on mvt.  
 
Weeks 1, 4 & 12 
















21. Shanahan, E. M., Ahern, 
M., Smith, M., Wetherall, M., 
Bresnihan, B., and FitzGerald, 
O. (2003) 'Suprascapular 
Nerve Block (using 
Bupivacaine and 
Methylprednisolone Acetate) 
in Chronic Shoulder Pain'. 
Annals of the Rheumatic 








duration of Sx 








SSNB Vs placebo (saline). 
 




Indirect approach.  
ROM. 
Pain (VAS) at rest, at 





Week 1, 4 & 12. 
ss improvements in all 
pain scores SSNB gp 
compared to baseline 
and to control at week 
1, 4 & 12. 
 
Some ss improvement 
in ROM scores at week 
1, 4 & 12 compared to 
control and baseline. 
22. Karataş, G. K. and Meray, 
J. (2002) 'Suprascapular 
Nerve Block for Pain Relief in 
Adhesive Capsulitis: 
Comparison of 2 Different 
Techniques'. Archives of 
Physical Medicine and 




@ least 4 
weeks 









Unguided SSNB (indirect) 
Vs EMG guided SSNB.  
10ml 1% lidocaine. 
 
AROM   
PROM 
Pain on PROM (VAS)  
@ Baseline, 10 minutes 
& 60 minutes. 
 
Both gps sig 
improvements in 
AROM, PROM & pain 
at 10 & 60 min. 
  
EMG block had a 
greater reduction in 
pain at 10 & 60 
minutes - SS compared 
to unguided.  
23. Vecchio, P. C., Adebajo, A. 
O., and Hazleman, B. L. (1993) 
'Suprascapular Nerve Block 
for Persistent Rotator Cuff 
Lesions'. The Journal of 







duration of Sx 
(30 / 33) 






SSNB n10 Vs 
RCT. 
 
i. SSNB Vs placebo (saline) 
for tendinitis group. 
 
ii. SSNB Vs placebo (saline) 




& 1ml 0.5% bupivacaine.  
Pain at night, pain on 
mvt, pain at rest (VAS). 
Presence of painful arc 
graded (0 no painful 
arc, 1 slight pain, 2 
moderate pain and 
weakness, 3 severe 




Weeks 1, 4 & 12 
SSNB Tendinitis gp had 
ss improvement in 
night pain @ weeks 1, 




SSNB Tear gp 
Has ss improvement in 
night pain week 1 & 4 
and ss improvement in 











Age (54 / 47) 
(70 / 70) 
M13 
F 15 
2ml saline.  
Direct approach.  
 
No between gp 
analysis.  
24. Rowlingson and Arasi  
(1986) 'The use of 
Suprascapular Nerve Blocks in 
the Management of Shoulder 







years  n36 
101 injections 
mean no. 
blocks per pt. 









Both SSNB and SAI 
 


























Appendix 4: Consent Form 
A focus group exploring clinician views and experiences on the role of 
Suprascapular nerve block injections in the conservative management of shoulder 
pain. 
Please initial box  
1. I confirm that I have read the information sheet version 1.0 dated 12th January 2016 
for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason. 
 
 
3. (If appropriate) I understand that the information collected about me will be 
used to support other research in the future, and may be shared anonymously 
with other researchers. 
 
4. I will respect the confidentiality of other research participants.  
 
5. I understand that the focus group session will be recorded for transcription. 
 
 
6. I agree to take part in the above study. 
 
            
Name of Participant  Date    Signature 
 
            




Appendix 5: Participant Information Sheet  
 
Research Title: A focus group exploring clinician views and experiences on the role 
of Suprascapular nerve block injections in the conservative management of 
shoulder pain. 
You are invited to take part in a study investigating the role of suprascapular nerve 
block (SSNB) injections in the conservation management of shoulder pain. The 
study is being undertaken by Neil Smith, Senior Physiotherapist, Sandwell and 
West Birmingham Hospitals NHS Trust within a NIHR MRes programme based at 
the University of Coventry.  
1. What is the purpose of this study?  
The purpose of this study is to explore the views, experiences and opinions of 
clinicians who currently undertake SSNB in the conservative management of 
shoulder pain in their clinical practice. The objectives are to identify and 
uncertainties in practice and areas where knowledge and research is lacking. The 
findings from the study may go on to inform future research in this area.  
2. Why have I been invited to participate in this study?  
You are invited to participate in this study because you are a clinician working in 
the NHS within the West Midlands and you currently administer SSNB in your 
clinical practice for the conservative management of shoulder pain.  
3. What will the study involve?  
If you agree to participate you will be asked to sign a consent form. The study will 
involve a Focus Group that will be held at City Hospital, Sandwell and West 
Birmingham Hospital NHS Trust at the beginning of February 2016. It is anticipated 
that the Focus Group will consist of between 6-10 participants from a variety of 
professional backgrounds such as Pain Consultants, Shoulder Surgeon, 
Rheumatologists, Nurses and Physiotherapists. The group will run for 
approximately 1-2 hour. The session will be run by Neil Smith, Jo Perry (Coventry 
University) and Ann Green (Coventry University). In the focus group session you 
will be asked questions by the facilitator (JP) relating to your clinical practice of 
treating patients with SSNB. You will be encouraged to discuss responses and 
themes within the group. The sessions will be recorded for transcription data 
analysis.  
4. Are there any risks to me taking part?  





5. How is the study being paid for?  
The study is being funded by the NIHR. Part of an MRes project at Coventry 
University  
6. Will I be paid?  
There will be no payment for taking part in this study?  
7. Do I have to take part in this study?  
Taking part in this study is completely voluntary and you can withdraw from the 
study at any time. However once the data is collected and stored, any data that 
you have provided will not be able to be withdrawn. 
8. Can I be identified in the study?  
No. Any information you provide in the focus group will be collected in a de-
identified form. The data will be stored on an encrypted USB. After completion of 
the study all data will be stored for 5 years and then destroyed.  
9. What happens to the results?  
The results will be analysed and presented in an academic report within a Thesis 
of the authors MRes. The findings may also be published in a scientific journal and 
may also be presented at a professional conference.  
10. Who should I contact if I would like to know more about this study?  
If you would like to know more about this study at any stage please contact Neil 





Appendix 6: Email to potential participants 
 
Dear all, many t hanks for previ ousl y i ndi cati ng t hat you woul d be i nterested i n taki ng part i n my NI HR funded research - a cli nician 
focus group l ooki ng at t he rol e of suprascapul ar nerve bl ock i nj ecti ons i n t he conservati ve manage ment of shoul der pai n. I j ust recei ved 
NHS et hi call y appr oval yest erday t o start recruiti ng partici pants for t he focus group sessi on. I have attached t he partici pat i ng i nfor mati on 
leaflet (PI L) for your i nfor mati on.  
 
The focus group will onl y i ncl ude cli nicians, no patients are i nvol ved. I have 3 pr ovisi onal dat es so far for t he sessi on: Tuesday 12t h 
April, Monday 18t h April and Thursday 21st April, ti mes t o be confir med but probabl y late afternoon due t o cli nical commit ments. 
(Pl ease i gnore t he dat es on t he attached PI L).  
 
I hope t o get represent ati on from all t he professi onal groups undertaki ng SSNB injecti ons - so your i nput woul d be very much 
appreci ated if you are free t o attend.  
 
Thi s i nitial research will lead ont o an appli cati on for NI HR fundi ng t o undertake a larger cli nical st udy.  
 
Pl ease let me know if you can make any of t he dat es or wish t o have any furt her i nfor mati on. I am also very happy t o come and tal k t o 
peopl e i ndi vi duall y t o expl ai n i n more det ail.  
 
 
Ki nd Regards 
 
Neil Smit h 
Physi ot herapist 
Sandwell Communit y Muscul oskel etal Servi ce  & Communit y Ort hopaedi c Servi ce 





Appendix 7: Focus Group Topic Guide:  
Clinician views / experiences on the role of SSNB injections in the conservative 
management of shoulder pain  
Overview and background to research: 
You are invited to this focus group as we would like you to share your views and 
experiences of the use and role of SSNB in the conservative management of 
shoulder pain. 
Ground rules - confidentiality and respect, relaxed environment with discussion.  
The session will be recorded and later transcribed. Key themes will be identified 
from the transcript and will be returned for your verification prior to writing up the 
full report.  
Each participant introduces themselves and their professional role.  
Topic Guide:  
1. From your experience could you explain how you would decide which 
patients with shoulder pain receive a SSNB injection. 
 
Diagnostic criteria- (subacromial pain, frozen shoulder, rotator cuff tears). 
Does duration or severity of symptoms / pain form part of the decision 
making process.  
Do you have any concerns with other shoulder injections that influences 
your decisions to consider a SSNB. 
Are there any age restrictions.  
If they have failed other treatments does this influence your decision.  
If a patient is awaiting surgery would you consider a SSNB. 
 
2. Once you’ve decided that a patient is appropriate for consideration of 
a SSNB injection what normally happens next?  
Consent. 
Patient information.  
Discussion of risks & contraindications.  





3. Could you describe what's involved when you perform a SSNB 
injection? 
 
How do you perform the procedure?  Patient position / injection approach / 
medication used. 
Positioning patient. 
Land marked or ultrasound guided injection. 
Techniques / aseptic. 
Drugs, dosages, volumes. 
Aftercare advise. 








Potential adverse effects. 
Wait after injection. 
What to do if concerned. 
How often would you repeat a SSNB injection. 
 
6. Do you teach any shoulder exercises or refer to any other services 
after the injection? 
Physiotherapy referral. Where. Concerns regarding delays.  
When to start exercises.  
7. Do you feel research is needed to answer any uncertainties or gaps in 
knowledge regarding SSNB injections?  
What kind of research would help in the future? 
Would further research help you decide which patients would benefit from a 























Appendix 9: Email to moderator to verify field notes 
 
 
Hi Jo  
I have attached the paper notes / reflection that I made immediately after the focus group session. On 
reflection I think it would be useful for you to quickly review my notes to verify if you feel they accurately 
capture the focus group. Any comments are very welcome as I can put these in analysis section for 









Yes, these seem to capture the pre-, peri- and post-event reflections. 
I would agree that all the participants were very generous with their own experiences and reflections on the 






Appendix 10: Data analysis coding strategy 
Transcription  1. The data have been transcribed to an 
appropriate level of detail, and the transcripts 
have been checked against digital recording 
for accuracy 
Coding 2. Each data item has been given equal attention 
in the coding process. 
3. Themes have not been generated from a few 
vivid examples (an anecdotal approach), but 
instead the coding process has been 
thorough, inclusive and comprehensive. 
4. All relevant extracts for each theme have been 
collated. 
5. Themes have been checked against each 
other and back to the original data set. 
6. Themes are internally coherent, consistent 
and distinctive. 
Analysis 7. Data have been analysed – interpreted, made 
sense of – rather than just paraphrased or 
described. 
8. Analysis and data match each other – the 
extracts illustrate the analytic claims. 
9. Analysis tells a convincing and well-organised 
story about the data and topic. 
10. A good balance between analytic narrative 
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and illustrative extracts is provided. 
Overall 11. Enough time has been allocated to complete 
all phases of the analysis adequately, without 
rushing a phase or giving it a once –over-
lightly. 
Written report 12. The assumptions about, and specific approach 
to, thematic analysis are clearly explicated. 
13. 13. There is a good fit between what you claim 
you do, and what you show you have done – 
i.e., described method and reported analysis 
are consistent. 
14. The Language and concepts used in the 
report are consistent with the epistemological 
position of the analysis. 
15. 15. The researcher is positioned as active in 
the research process; themes do not just 
‘emerge’. 










Detailed description of the data analysis process 
Phase 1: Familiarising yourself with your data. 
I read the transcript several times and checked for accuracy against the digital 
recording file. I made amendments were made to the transcript document due to 
transcription errors with transcriber misinterpretation of certain words of medical 
terminology; for example, the transcriber had written ‘innovation’ instead of 
‘denervation’ and this was corrected. 
The transcript was then re-formatted to facilitate the data analysis process. The 
margins of the word document were widened to enable codes to be captured next 
to the specific text that they related to. Line numbers were also added so that 
during later analysis, codes could be traced back to the transcript, that would 
provide context for the coded text in relation to the wider discussions it was taken 
from.  
The returned original transcript had also been formatted by the transcriber with 
labels identifying the moderator text with Q (presumably for question) and 
participants text labelled A (presumably for answers).  
From listening to the recording and verifying against the transcript document I was 
able to change these labels from Q to M for the moderator and from A to P1, for 
participant one, P2 for participant two, P3 for participant three, P4 for participant 
four and P5 for participant five, for the individual participant responses and 
comments respectively throughout the transcript. This process was implemented to 
facilitate the data analysis process and it was also felt that labelling the responses 
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in this way would maintain anonymity of the participants if transcripts were ever 
viewed by people outside of the research team at a later date.  
Phase 2: Generating initial codes. 
This phase involved me highlighting sections of text that I felt was important, 
recurring, interesting and / or relevant to the purpose, aims and objectives of the 
study. The highlighted text was given a descriptive ‘code’ in the right hand margin 
of the transcript (appendix).  The original text and descriptive codes were colour 
coded with a highlighter pen to support the data extraction and collating process. 
Text and codes with similar meaning were all colour coded the same colour. I 
started this process from the beginning of the transcript and adopted the same 
systematic approach throughout the text.  
Once this process was complete for a given code, the transcript was re-read from 
the beginning and the whole process repeated for the next different set of codes. 
This process was then repeated again and again until the whole document had 
been coded.  
At times it was apparent that a section of text, that had previously been coded, also 
appeared to align with another new set of codes. If this the text was given a second 
code and colour.  
Once the coding process was complete the codes and associated text were 
collated in tables (appendix). Codes of the same colour i.e. codes that had similar 
meanings or were related in some way, were grouped together in the table. In 
addition, line numbers relating back to the original text were included in the table 
151 
 
next to the codes to identify from where the code originated in the original 
transcript so to understand and appreciate the context of the code in relation to the 
original discussion taking place.   
At the end of phase 2, five different groups had initially be identified, collated and 
tabulated. At this stage these groups were not yet given a heading name or 
potential theme name. 
Phase 3: Searching for themes. 
This phase of the data analysis process involved reviewing the five groups of 
codes and text with the objective of identifying potential themes. The codes were 
reviewed in relation to the transcript to provide context. This process was simplified 
by the line numbers as the code could be traced back to the transcript easily. At 
this point potential themes were generated and the groups of codes were given 
potential theme names. 
Phase 4: Reviewing themes. 
The grouped codes and text were then considered along with all the data items i.e.  
the field notes, notes made whilst initially listening to the digital recording, the 
transcription document and the digital recording. In essence four data sets were 
used for triangulation. This combined approach of reviewing multiple sets of data 
was adopted to triangulate the data that was captured in different ways and at 
different times.  
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During this process, codes were further analysed and regrouped under potential 
themes. On reflection this process was very time consuming and challenging. 
I continually deliberated on which codes fit under which potential theme. I moved 
backwards and forwards across the different data sets to gain a deeper 
appreciation of the context of the text and code within the wider discussions.  
At the end of phase 4, I had identified five potential themes. A thematic map of the 
themes was now produced.  
Phase 5: Defining and naming themes. 
At this stage two meetings were arranged with two different members of my 
academic supervision team.  (AG & JP). JP was also the focus group moderator.  
The meeting with JP involved discussion of the process of theme construction and 
displaying themes.The meeting with AG involved collaboration and verification on 
themes. (AG) who had constructed themes independently to the researcher. This 
collaborative analysis allowed the researcher and the co-researcher to discuss and 
re-analyse the codes together to identify three main themes.  
Phase 6: Producing the report. 
 This phase involved relating back the analysis to the research question and 
literature, producing the thesis document] 
Refection: 
In reality the data analysis process started much earlier than reading the transcript 
document. It could be argued that the analysis process started immediately after 
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the focus group session when documenting initial thoughts and reflections, or it 
could even be argued that some initial subconscious analysis took place during the 
focus group session itself, whilst contributing to the discussions with other 
participants.  
The process of checking the transcript accuracy and reformatting the transcript to 
facilitate data analysis meant I had to read and re-read and listen and re-listen to 
the data several times. Although not necessarily regarded as data analysis directly 
the process of re-reading and re-listening meant that I became extremely 
familiarised and immersed within the data so that at a subconscious level data 
analysis was automatically taking place. 
Coding strategy: 
From re-reading the transcript over and over again, it also became apparent, that 
although text with similar content, tended to be grouped closely together in the 
transcript, that were based on and in response to the previous moderator question; 
this was not always the case. Throughout the transcript sections of text appeared, 
where the content was not directly related to the previous moderator question.  
Although participants tended to respond to questions with related responses, at 
times they also expressed views and experiences unrelated to the immediate 
question or their initial responses led them and others onto new areas and topics of 
discussion. This observation required me to adopt a process and strategy for 
coding similar and related text throughout the transcript, in a systematic manner. 
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Without this systematic approach important data extracts and information may 




Appendix 11: Collated data and codes table  
 
Line No. Text Descriptor / code 






























Divide up pathologies 
Inflammatory /Mechanical 
problem 









Duration of pain & 
symptoms 
 
Unsuitable for surgery 
 
 
Tried everything else 
 
 

















Duration of pain / Sx 
 
 
No other options 
 
 































Does not want surgery 
 
 
Try injection before surgery 
 
Previous literature indicated 
chronic pain 
 
SSNB Less risks to rotator 
cuff 
 
Try subacromial injection in 
subacromial pain 
 





























Line No. Text Descriptor / code 
  Patient Management 
28, 367, 683 
 
 
Ref for phyio ex’s after 











































Last up to 3 months?  
























Diagnostic - Pathways / Repeat 
injection / resources 
 















Adjuct Rx, window of opportunity. 
Realise the benefit of the injection 
 
 
Benefit 3/12 Evidence / normal 





















Talk through procedure, 
benefit & risks, informed 
consent, practice, patient 
advice 
Trust because of expertise? 
 
 
Communication / risk management 
 
 
Line No. Text Descriptor / code 

























Inject artery / vein 
 
Talk through procedure, 
benefit & risks, informed 


















Technique / approach 
 


































LA or LA + Depo 
 
 




Approach / technique / risk 
management 
 
Communication / risk management 
 
Variable drugs, volumes, based on 
training, PGD, US vs landmarked 
 
Evidence vs practice 
 
 
Safety vs effectiveness? 
 
 
Line No. Text Descriptor / code 













Specific outcome measures 
SPADI / Quick DASH 
 
 
Patient reported - 



























Line No. Text Descriptor / code 

























LA alone  
 




Effective before chronic pain 
established  
 
Can we be more selective 
regarding pathologies or any 
shoulder condition. Compare 
to existing treatment i.e. SAI.  
 
Adjunct treatments SSNB + 
physio  














Patient selection  
































Appendix 13: Email participant verification of themes 
 
 
On Wed, May 25, 2016 at 2:00 AM -0700, "Smith Neil (SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST)" 
<neilsmith2@nhs.net> wrote: 
 
Hi all, thank you again for participating in my focus group on the role of SSNB injection in the non-surgical management of 
shoulder pain. I am currently busy writing up the findings for the 10th June!  
We discussed that I would send you the themes that came out of the focus group for verification. 
3 main themes were identified please let me know if you feel this was accurate representation of your view and experinces. 
 
 ‘Patient Selection’  
2 main observations were, generally patients have ‘failed other treatments’ and have ‘long standing shoulder pain’ often 
several months or more. Other important factors considered were SSNB injection previously helped, direct referral for a 
SSNB injection, unsuitable for surgery, doesn’t want surgery and risk of repeat local steroid injection. 
 
‘The Intervention’  
Both surface landmarked and ultrasound guided approaches are used. Clinicians that use ultrasound guided approaches use 
less drug volume and have more confidence mitigating potential risks of undertaking SSNB injections due to needle 
positioning and placement accuracy afforded by ultrasound guided techniques. The major risks discussed were injury to the 
SSN and artery, injection of bolus into the artery, pneumothrorax, depigmentation,  and infection.  
 
‘Patient Management’  
Physiotherapy and shoulder exercises were viewed has an integral part of the overall patient management. 
Clinicians felt that it was appropriate to repeat SSNB injections at a minimum 3 month intervals and repeat injections could 
be ongoing if seen to be beneficial to the patient.  
If the relief provided by a SSNB injection was short lived consideration for a SSN denervation procedure is considered for 
some patients.  
Outcome measures and clinical audit data are not routinely collected by the clinicians with the exception of one clinician who 
reports the regular use of the Disabilities of the Arm, Shoulder and Hand (DASH) and the Shoulder Pain and Disability Index 




•       Identifying if SSNB injections were as effective as local steroid injection in specific shoulder conditions such as 
subacromial pain.  
•       If SSNB injections are effective in patients with less established chronic pain.  
•       Whether SSNB injections add further value if combined with other injections and procedures such has combining with 
hydrodistension for frozen shoulder. 
•       New methods of delivery of drug to the SSN such as lidocaine patches & long lasting LA   
•       Continued research to furthering our understanding of the basic science of Pain and specifically our understanding on 
how a SSNB injection could improve symptoms beyond the pharmacological effect of the drug used. 
•       Clinicians identified research establishing the value and benefit of combining SSNB injections with physiotherapy 
intervention 






Thank you Neil. It is probably a true representation of what we discussed. 
Dr A T Arasu Rayen DA (Ind), DA (UK), FRCA, FFPMRCA, MSc (Pain Management), Cert Med Edu, FHEA 
Consultant in Pain Management and Anaesthetics  
 
Hi  Neil, 
 














Appendix 15: The transcript example  
FOCUS GROUP MEETING 
 
TRANSCRIBED ON BEHALF OF  
NEIL SMITH 
FOR 
SANDWELL MUSCULOSKELETAL & ORTHOPAEDIC SERVICE 
 
SUBJECT 
SUPRASCAPULAR NERVE BLOCK INJECTION 
 
DATE TRANSCRIBED  
26/04/2016 
 









TRANSCRIPTIONIST - LESLEY NASH  
 
 
 THOSE PRESENT:   IDENTIFIED AS: 
 
 Questions by Facilitator   Q 






Q Right then we will start off with question one.  So from your experience, can you 
explain how you would decide which patients with shoulder pain were seen for a 
suprascapular nerve block injection? 
A Personally when I've evaluated the patients clinically, I've obviously examined their 
shoulder and I've first established what I feel the anatomical or the explanation for 
what their shoulder is and I would personally divide up my pathologies into 
inflammatory problems that are I think amenable to a different type of approach 
which is a steroid injection or a mechanical problem that needs further 
investigation and then the mechanical problem has failed to respond to other 
modalities and that could be osteoarthritis or it could be severe rotated cuff 
disease where there's no surgical option for, or it could be a severe capsulitis of 
the shoulder or a frozen shoulder that hasn’t responded to other therapies and if it 
falls into any of those categories, I would then consider them for a suprascapular 
nerve block, it would be a pain relieving procedure. 
Q That’s your core decision making then? 
A Yes. 
Q Another? 
A So it was a similar situation probably by assessing the patient and how far the pain 
is there, that is one of the important facts and if it has been there for ages and not 
responded for physiotherapy, previous injections, manipulations and if they are 
still in pain and then after going through all the investigation procedures, other 
things that can be ruled out like 01:54.  In that case I'd consider a nerve block 
injection.  That’s mainly for pain relief as well as to improve the functions and then 
refer them for further physiotherapy, other exercises. 
A  We tend to use it as almost like an injection of last resort, particularly in the 
patients that have comorbidities which means they are unsuitable for surgery, so 
we will try suprascapular nerve block if everything else has failed. 
Q Right that’s interesting, what about you? 
A Yes I think I'm in a similar position that the majority of patients I've chosen to have 
a nerve block have almost tried everything else first, but when I reflect on that I 
don’t know why that is the case because I don’t know why it needs to be the last 
choice.  In my practice I've often questioned myself why I haven't offered them a 
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suprascapular nerve block before, a intraarticular or subacromial injection and I 
















Appendix 17: Trustworthiness / Methodology /  Data display (JP) 
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